Obesity, other/unspecified

E4_OBESITYNAS

obesity: A disorder involving an excessive amount of body fat.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — E66.8, E66.9 Hospital discharge: ICD-9 — 2780 Hospital discharge: ICD-8 — 27799 Cause of death: ICD-10 — E66.8, E66.9 Cause of death: ICD-9 — 2780 Cause of death: ICD-8 — 27799 2 out of 7 registries used, show all original rules.	19784
4. Check minimum number of events None	19784
5. Include endpoints None	19784
6. Filter based on genotype QC (FinnGen only)	17743

Control definitions (FinnGen only)

Control exclude: E4_OBESITY

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2

NAME	E4_OBESITYNAS
CONTROL_EXCLUDE	E4_OBESITY
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	E66[8-9]
HD_ICD_9	2780
HD_ICD_8	27799
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	E66[8-9]
COD_ICD_9	2780
COD_ICD_8	27799
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Obesity, other/unspecified based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	101521	63163	37539
Only index persons	87711	55646	32065
Unadjusted period prevalence (%)
Whole population	1.52	1.81	1.05
Only index persons	1.75	2.05	1.22
Median age at first event (years)
Whole population	48.13	47.17	49.69
Only index persons	46.49	45.16	48.82

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	17743	12576	5167
Unadjusted period prevalence (%)	3.85	4.46	2.37
Median age at first event (years)	48.72	46.79	53.42

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
18430: Matched controls
184290

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.1

322.5

4080

22361

B01AB04

ATC

dalteparin; parenteral

3.4

318.2

1245

3897

ZXE10

NOMESCO Finland

More than one and less than three hours

1.9

318.0

6548

42242

XX_20

NOMESCO Finland

Bioimpedance measurement

45.3

312.4

184

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.4

310.3

2433

10981

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

2.4

308.9

2540

11705

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

3.7

308.7

1017

2845

A10AB05

ATC

insulin aspart; parenteral

3.2

307.7

1762

5962

B01AB05

ATC

enoxaparin; parenteral

2.8

307.7

7147

34399

M79.6

ICD-10 Finland

Pain in limb

1.9

307.7

9102

62942

A10BB12

ATC

glimepiride; oral

5.2

307.7

1471

3047

M54.5

ICD-10 Finland

Low back pain

1.9

307.7

7818

51826

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

2.0

307.7

8917

59425

C07AB07

ATC

bisoprolol; oral

2.1

307.7

8289

52257

A08AB01

ATC

orlistat; oral

36.3

307.7

464

131

WX722

NOMESCO Finland

PEEP

5.3

307.7

1254

2512

205

Kela drug reimbursment

Chronic hypertension

3.0

307.7

4814

19609

R4110

NOMESCO Finland

Physiotherapy

2.0

307.7

5500

32084

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

5.8

307.7

776

1398

R02

ICPC

Shortness of breath/dyspnoea

2.3

307.7

2829

13302

JDF11

NOMESCO Finland

Laparoscopic gastric bypass

4719.7

307.7

2884

JDF01

NOMESCO Finland

Laparoscopic gastroplasty

1808.7

307.7

829

L17

ICPC

Foot/toe symptom/complaint

2.0

307.7

6233

38139

N06AX16

ATC

venlafaxine; oral

2.5

307.7

3782

17565

N02BE01

ATC

paracetamol; systemic, rectal

2.9

307.7

16989

147411

N06AX21

ATC

duloxetine; oral

2.4

307.7

2968

13477

XG466

NOMESCO Finland

Sleep oxymetry

7.5

307.7

1092

1535

WX780

NOMESCO Finland

Remote monitoring CPAP

3.9

307.7

1282

3502

OAB72

NOMESCO Finland

Weight control and weight loss guidance

28.7

307.7

726

263

E66.01

ICD-10 Finland

Obesity due to excess calories

45.5

307.7

8806

3630

O24.4

ICD-10 Finland

Diabetes mellitus arising in pregnancy

2.8

307.7

2404

9371

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.8

307.7

6687

31483

G47.3

ICD-10 Finland

Sleep apnoea

6.0

307.7

8534

23117

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

3.5

307.7

3565

11811

T83

ICPC

Overweight

6.0

307.7

1044

1836

M17.1

ICD-10 Finland

Other primary gonarthrosis

2.4

307.7

4195

19995

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.6

307.7

2568

10632

C08CA01

ATC

amlodipine; oral

2.1

307.7

6427

37940

A08AA62

ATC

bupropion and naltrexone; systemic

14.3

307.7

471

338

215

Kela drug reimbursment

Diabetes, non-insulin-treated

4.2

307.7

6630

21840

N03AX16

ATC

[U] pregabalin

2.1

307.7

4689

25265

C03DA01

ATC

spironolactone; oral

3.2

307.7

2647

9156

C03CA01

ATC

furosemide; systemic

3.7

307.7

6192

22406

A10BJ01

ATC

exenatide; parenteral

15.2

307.7

447

300

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

9.9

307.7

3001

3560

I10

ICD-10 Finland

Essential (primary) hypertension

2.9

307.7

11694

68467

310

Kela drug reimbursment

Orlistat, sibutramine and other major and expensive medicines used to treat obesity

32.0

307.7

780

254

L15

ICPC

Knee symptom/complaint

2.0

307.7

5129

29945

N05AH04

ATC

quetiapine; oral

2.3

307.7

4197

21264

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

2.5

307.7

2376

10168

A10BK03

ATC

empagliflozin; oral

4.0

307.7

2681

7521

A46

ICD-10 Finland

Erysipelas

3.3

307.7

3534

12341

R4190

NOMESCO Finland

Nutritional therapy

9.5

307.7

2257

2662

R03AC02

ATC

salbutamol; inhalant

2.2

307.7

11764

81777

E66.8

ICD-10 Finland

Other obesity

485.9

307.7

12826

864

T82

ICPC

Obesity

14.7

307.7

3322

2714

I50.0

ICD-10 Finland

Congestive heart failure

3.8

307.7

1212

3374

A02BC02

ATC

pantoprazole; systemic

2.4

307.7

13549

99726

27799

ICD-8 Finland

Obesity not specified as of endocrine origin

+∞

307.7

1032

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

9.5

307.7

2770

3359

E66.00

ICD-10 Finland

Metabolic syndrome

29.4

307.7

4012

1725

N02AX02

ATC

tramadol; systemic, rectal

2.7

307.7

9673

53506

N02AJ06

ATC

codeine and paracetamol; systemic

1.9

307.7

8860

60230

R60.0

ICD-10 Finland

Localized oedema

2.7

307.7

2753

11173

E66.1

ICD-10 Finland

Drug-induced obesity

81.7

307.7

226

A10BX04

ATC

[U] exenatide

25.0

307.7

575

237

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

2.8

307.7

2820

11026

SPAT1262

SPAT

Handing over of treatment supplies

3.0

307.7

3753

14532

A10AE04

ATC

insulin glargine; parenteral

3.8

307.7

2469

7255

R5140

NOMESCO Finland

Monitoring the use of the aid

5.5

307.7

3991

8799

B03BA03

ATC

hydroxocobalamin; parenteral

4.2

307.7

1312

3303

358

Kela drug reimbursment

liraglutide

24.0

307.7

253

107

T90

ICPC

Diabetes non-insulin dependent

4.1

307.7

6312

20869

QBJ30

NOMESCO Finland

Correction of abdominal apron

42.9

307.7

915

224

A10BJ02

ATC

liraglutide; parenteral

15.4

307.7

1820

1306

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

2.9

307.7

2929

11166

Z3226

NOMESCO Finland

Physiotherapist

2.5

307.7

4018

18311

A08

ICPC

Swelling

3.5

307.7

1300

3926

G56.0

ICD-10 Finland

Carpal tunnel syndrome

2.3

307.7

3160

15416

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

3.1

307.7

2862

10218

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

391.3

307.7

929

N06AB03

ATC

fluoxetine; oral

2.6

307.7

3004

12818

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

6.1

307.7

712

1198

M04AA01

ATC

allopurinol; systemic

3.6

307.7

2612

8169

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

2.9

307.7

2859

11070

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

6.5

307.7

1392

2300

J01FF01

ATC

clindamycin; systemic

2.2

307.7

5801

32067

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

2.7

307.7

2720

11018

M10.9

ICD-10 Finland

Gout, unspecified

3.4

307.7

1294

3998

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

2.1

307.7

3966

21136

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

5.2

307.7

6922

19074

I50.9

ICD-10 Finland

Heart failure, unspecified

3.3

307.7

2338

7701

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.5

307.7

3492

16016

Z3231

NOMESCO Finland

Registered nurse

2.1

307.7

5509

30603

K76.0

ICD-10 Finland

Fatty (change of) liver, not elsewhere classified

4.5

307.7

916

2098

162

Kela drug reimbursment

liraglutide

23.2

307.7

605

269

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

5.2

307.7

697

1391

A10BX07

ATC

[U] liraglutide

25.1

307.7

708

293

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

9.0

307.7

2422

3032

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

4.9

307.7

2854

6595

E66

ICD-10 Finland

Obesity

14.1

307.7

4411

4028

E66.0

ICD-10 Finland

Obesity due to excess calories

577.0

307.7

774

C09AA02

ATC

enalapril; systemic

2.4

307.7

3243

14812

A10BG03

ATC

pioglitazone; oral

6.2

307.7

658

1089

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

3.6

307.7

3525

11258

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

4.9

307.7

761

1594

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

3.2

307.7

3259

11755

A10BK01

ATC

dapagliflozin; oral

3.7

307.7

1905

5557

RD210, ,

NOMESCO Finland

12.4

307.7

961

812

A10AC01

ATC

insulin (human); parenteral

3.8

307.7

1948

5577

E11

ICD-10 Finland

Type 2 diabetes mellitus

4.2

307.7

4241

12281

2780A

ICD-9 Finland

Obesity and other hyperalimentation, Obesity

+∞

307.7

855

A10BJ05

ATC

dulaglutide; parenteral

9.1

307.7

797

910

160

Kela drug reimbursment

exenatide

23.2

307.7

1164

533

N06AB04

ATC

citalopram; systemic

2.1

307.7

4394

24064

J45.9

ICD-10 Finland

Asthma, unspecified

2.6

307.7

4569

21037

L28

ICPC

Limited function/disability (L)

2.3

307.7

3485

16859

A10BH01

ATC

sitagliptin; oral

4.6

307.7

2505

6120

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.7

307.7

2445

9961

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

2.3

307.7

6617

36072

S97

ICPC

Chronic ulcer skin

3.7

307.7

1415

4006

A10BJ06

ATC

semaglutide; parenteral

8.7

307.7

2507

3267

3055, ,

Kela drug reimbursment

15.4

307.7

475

317

OAB72, ,

SPAT

6.8

307.7

714

1088

103

Kela drug reimbursment

Diabetes, insulin-treated

4.4

307.7

7154

23213

A08AA02

ATC

fenfluramine; oral

12.1

307.7

348

292

A08AA10

ATC

sibutramine; oral

30.3

307.7

248

A10BA02

ATC

metformin; oral

5.5

307.7

8465

24795

N06AX12

ATC

bupropion; oral

2.8

307.7

2179

8553

R06.0

ICD-10 Finland

Dyspnoea

2.3

307.7

5596

29399

C03AA03

ATC

hydrochlorothiazide; oral

3.1

307.7

1627

5652

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

2.4

307.7

4617

22277

E66.9

ICD-10 Finland

Obesity, unspecified

164.8

307.7

7080

695

J01DB01

ATC

cefalexin; oral

2.4

307.7

15994

135097

3051, ,

Kela drug reimbursment

13.1

307.7

663

524

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.1

307.7

8793

55817

H02AB06

ATC

prednisolone; systemic

1.9

307.7

9178

63494

A10BB01

ATC

glibenclamide; oral

5.1

303.4

650

1306

J96.1

ICD-10 Finland

Chronic respiratory failure

6.7

303.4

488

746

A10AE05

ATC

insulin detemir; parenteral

3.3

302.2

1201

3793

C10AA01

ATC

simvastatin; oral

1.9

301.7

5751

36084

S18

ICPC

Laceration/cut

1.8

301.6

8492

59893

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

6.1

296.4

519

865

WX110

NOMESCO Finland

Infiltration anesthesia

1.9

296.3

14047

115248

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

2.6

295.8

1911

7873

WX723

NOMESCO Finland

CPAP therapy

3.4

295.6

1129

3478

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

4.2

294.5

825

2056

B81

ICPC

Anaemia vit B12/folate deficiency

4.1

294.1

836

2106

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

4.1

292.5

838

2123

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.7

289.7

1646

6356

J01CE08

ATC

benzathine benzylpenicillin; parenteral

8.7

287.8

367

430

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.6

285.5

1769

7135

P06

ICPC

Sleep disturbance

2.1

284.4

3061

15711

XCK10

NOMESCO Finland

Photography of fundus of eye

2.6

283.7

1749

7036

J01DA01

ATC

[U] cefalexin

1.8

278.1

11640

90990

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.9

277.8

4298

25094

R03AK06

ATC

salmeterol and fluticasone; inhalant

2.2

277.8

2752

13663

WX290

NOMESCO Finland

Other blockage of nerve

1.7

275.7

10003

75060

N06AB10

ATC

escitalopram; oral

1.9

275.4

4699

28316

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.6

275.1

1725

6994

A28

ICPC

Limited function/disability NOS

2.2

272.6

2676

13230

N05AX12

ATC

aripiprazole; systemic

3.2

272.1

1145

3739

J01AA02

ATC

doxycycline; systemic

1.9

270.4

14385

120173

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.8

269.7

5755

37114

T07

ICPC

Weight gain

4.9

269.6

600

1245

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.9

268.3

1361

4943

A10BH05

ATC

linagliptin; oral

3.6

268.1

914

2613

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.4

267.5

2053

9143

ZXD10

NOMESCO Finland

Scheduled procedure

1.8

267.0

6822

46320

JJA21

NOMESCO Finland

Laparoscopic biopsy of liver

24.2

266.1

189

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

3.4

265.0

987

2989

J45.1

ICD-10 Finland

Nonallergic asthma

2.7

264.8

1553

6085

J45

ICD-10 Finland

Asthma

2.3

264.1

2405

11523

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

2.1

263.3

2775

14093

C09BA02

ATC

enalapril and diuretics; systemic

2.9

262.3

1317

4755

H03AA01

ATC

levothyroxine sodium; systemic

1.9

260.7

4599

27932

P76

ICPC

Depressive disorder

2.5

259.8

1821

7777

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.3

259.7

2179

10083

R03BA02

ATC

budesonide; inhalant

2.0

258.9

3702

20985

N05BA04

ATC

oxazepam; oral

1.8

258.7

5154

32484

J01FA06

ATC

roxithromycin; oral

1.7

257.7

7419

51934

C02AC05

ATC

moxonidine; oral

3.6

257.3

891

2573

N03AX12

ATC

[U] gabapentin; oral

2.0

257.2

3105

16581

R03BB04

ATC

tiotropium bromide; inhalant

2.5

256.9

1729

7244

B01AA03

ATC

warfarin; systemic

2.2

255.9

2550

12658

4019X

ICD-9 Finland

Essential hypertension, Unspecified

5.6

254.1

488

888

K42.9

ICD-10 Finland

Umbilical hernia without obstruction or gangrene

3.1

254.1

1139

3857

C08CA13

ATC

lercanidipine; oral

2.2

253.9

2414

11758

Z3229

NOMESCO Finland

Other healthcare associate professional

2.6

248.6

1594

6521

A10BD07

ATC

metformin and sitagliptin; systemic

3.6

248.4

851

2439

3472A

ICD-9 Finland

Cataplexy and narcolepsy[OBSTRUKTIIVINEN UNIAPNEA]

9.2

247.7

302

334

S76

ICPC

Skin infection other

3.0

247.1

1179

4135

R60.9

ICD-10 Finland

Oedema, unspecified

2.9

246.5

1232

4433

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.3

246.2

2026

9285

M03BC01

ATC

orphenadrine (citrate); systemic

1.8

246.1

4737

29471

K02.1

ICD-10 Finland

Caries of dentine

1.7

245.1

11762

93789

Z71.8

ICD-10 Finland

Other specified counselling

1.7

244.1

7011

48843

QBJ05

NOMESCO Finland

Other correction of loose or redundant skin of trunk

64.3

243.5

134

M54.4

ICD-10 Finland

Lumbago with sciatica

1.9

242.5

3852

22552

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.7

241.3

7442

52793

N05CF01

ATC

zopiclone; oral

1.7

238.6

5555

36473

AA40B, ,

NOMESCO Finland

14.3

237.8

216

153

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

3.0

237.2

1145

4040

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

7.1

235.0

356

510

WX408

NOMESCO Finland

General anesthesy, balanced

1.8

234.8

4704

29548

J46

ICD-10 Finland

Status asthmaticus

3.7

234.0

761

2105

C09CA01

ATC

losartan; oral

1.8

233.3

4123

24928

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

2.0

233.1

2951

15977

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

5.7

233.0

442

795

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.2

232.4

2281

11228

R06.5

ICD-10 Finland

Mouth breathing

2.3

231.9

1884

8576

J01MA12

ATC

levofloxacin; systemic

2.0

231.9

3183

17722

JN3AD

NOMESCO Finland

Abdominal CT examination

2.1

231.9

2532

12986

R03DC03

ATC

montelukast; oral

1.9

231.9

3537

20401

N06AX11

ATC

mirtazapine; oral

1.7

231.4

6548

45269

Z2221

NOMESCO Finland

Medical doctor

1.7

230.3

5308

34686

P03

ICPC

Feeling depressed

2.1

228.2

2532

13059

I48

ICD-10 Finland

Atrial fibrillation and flutter

2.0

225.4

2647

13937

N06AB06

ATC

sertraline; oral

2.1

225.1

2560

13319

L03

ICPC

Low back symptom/complaint

1.7

224.1

5839

39404

I11.0

ICD-10 Finland

Hypertensive heart disease with (congestive) heart failure

4.8

223.7

510

1079

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.9

223.1

3722

22063

EBA00

NOMESCO Finland

Extraction of tooth

1.7

222.7

6915

48854

N03AX09

ATC

lamotrigine; oral

2.7

221.9

1285

4990

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

3.1

220.8

968

3231

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.7

219.6

1226

4672

Z02.7

ICD-10 Finland

Issue of medical certificate

2.4

218.8

1586

6858

WX402

NOMESCO Finland

General anaesthesia

1.8

218.4

4487

28297

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.0

218.3

2748

14819

R03AC03

ATC

terbutaline; inhalant

2.0

218.1

2815

15314

R03AK07

ATC

formoterol and budesonide; inhalant

1.8

218.0

4444

27960

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.4

217.3

1700

7603

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.6

216.9

10643

84051

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.8

216.8

3995

24388

TPH04

NOMESCO Finland

Cathetrisation of vein

1.8

216.8

3953

24056

C09AA05

ATC

ramipril; oral

1.9

216.6

3527

20723

F50.8

ICD-10 Finland

Other eating disorders

10.5

216.1

238

229

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.8

215.9

4432

27930

XF400

NOMESCO Finland

ECG with 12 standard connections

2.1

214.4

2480

12967

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.0

211.7

2647

14229

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.7

211.6

5239

34761

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.0

211.5

2536

13429

M03BX02

ATC

tizanidine; oral

1.6

209.9

11949

97499

M01AB05

ATC

diclofenac; systemic, rectal

1.6

209.5

12178

99865

M25.5

ICD-10 Finland

Pain in joint

1.6

209.1

6656

47120

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.7

207.3

5973

41202

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.2

207.3

1852

8756

A01

ICPC

Pain general/multiple sites

2.2

206.6

2033

9990

R03BA05

ATC

fluticasone; inhalant

1.8

206.6

3563

21278

ZXD05

NOMESCO Finland

Urgent procedure

1.7

206.5

5618

38173

2500A

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE,TYYPPI II]

5.8

204.6

378

663

N05AA02

ATC

levomepromazine; systemic

3.2

204.5

848

2737

E28.2

ICD-10 Finland

Polycystic ovarian syndrome

4.3

204.4

542

1293

ACC51

NOMESCO Finland

Release of median nerve

2.3

201.4

1618

7311

H02AB07

ATC

prednisone; oral

2.0

200.9

2454

13065

SPAT1139

SPAT

Nutrition survey

3.5

200.7

716

2104

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

2.4

199.9

1481

6457

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

4.7

199.8

473

1032

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.0

198.5

2551

13821

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.7

198.5

4625

30090

C09DA01

ATC

losartan and diuretics; oral

2.2

198.1

1771

8368

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.8

197.8

3817

23539

E78.9

ICD-10 Finland

Disorder of lipoprotein metabolism, unspecified

3.6

197.2

678

1945

M01AE02

ATC

naproxen; oral, rectal

1.6

196.9

10703

85692

C09DA06

ATC

candesartan and diuretics; oral

2.4

195.9

1389

5936

RD112, ,

NOMESCO Finland

18.7

194.8

154

K07

ICPC

Swollen ankles/oedema

3.1

192.9

841

2795

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.5

192.9

1276

5279

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

2.1

192.7

2123

10876

I50

ICD-10 Finland

Heart failure

4.4

191.8

486

1119

SPAT1008

SPAT

Photography of fundus of the eye or interpretation of photograph

3.5

191.4

697

2075

A10BX01

ATC

guar gum; oral

3.7

190.0

623

1731

J01MA02

ATC

ciprofloxacin; systemic

1.6

189.7

6527

46808

K04.08

ICD-10 Finland

Other specified pulpit

2.1

189.6

1880

9250

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.7

188.8

4942

33089

N17.9

ICD-10 Finland

Acute renal failure, unspecified

3.3

188.8

727

2242

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.5

188.8

1238

5099

SFA30

NOMESCO Finland

Three-surface restoration

1.6

187.9

7878

59150

A06AD11

ATC

lactulose; oral

2.0

187.6

2195

11488

R05FB02

ATC

cough suppressants and expectorants; systemic

1.6

186.8

6172

43792

O10.0

ICD-10 Finland

Pre-existing essential hypertension complicating pregnancy, childbirth and the puerperium

4.2

186.1

503

1217

S80.0

ICD-10 Finland

Contusion of knee

2.2

184.3

1735

8359

S10

ICPC

Boil/carbuncle

2.5

183.0

1262

5320

SPAT1305

SPAT

Counselling and guidance related to physical exercise

2.2

182.4

1654

7849

K42.0

ICD-10 Finland

Umbilical hernia with obstruction, without gangrene

5.6

181.8

350

638

D11

ICPC

Diarrhoea

1.9

181.5

2643

14899

Z2446

NOMESCO Finland

Social worker

2.4

180.4

1304

5615

H3600, E113,

ICD-10 Finland

7.2

179.8

267

374

N05BA01

ATC

diazepam; systemic, rectal

2.0

179.8

2286

12309

207

Kela drug reimbursment

Chronic arrhythmias

2.1

179.5

1984

10161

C10AA05

ATC

atorvastatin; oral

1.6

178.9

6146

43907

M01AE03

ATC

ketoprofen; systemic, rectal

1.6

178.9

6168

44102

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.6

178.6

9857

78405

SGA01

NOMESCO Finland

Emergency treatment

1.8

178.5

3487

21503

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.0

178.0

2205

11764

R03DA04

ATC

theophylline; systemic, rectal

3.0

177.7

831

2873

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.6

177.3

8876

69047

M01AH05

ATC

etoricoxib; oral

1.6

177.0

11671

96510

N02BF01

ATC

gabapentin; oral

2.0

176.6

2068

10812

J20

ICD-10 Finland

Acute bronchitis

2.0

175.8

2153

11437

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.2

175.3

1625

7775

K04.0

ICD-10 Finland

Pulpitis

2.0

174.6

2073

10890

A02BC01

ATC

omeprazole; systemic

1.7

173.9

4633

31047

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.7

173.6

3704

23393

C09CA06

ATC

candesartan; oral

1.7

173.5

4379

28935

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.6

172.7

7634

57654

F34.1

ICD-10 Finland

Dysthymia

2.8

171.8

904

3332

A12BA01

ATC

potassium chloride; oral

3.5

171.7

606

1767

ZXA00

NOMESCO Finland

Right side

1.7

171.7

4057

26335

M48.0

ICD-10 Finland

Spinal stenosis

2.1

171.4

1840

9313

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.6

171.0

5065

34831

L90

ICPC

Osteoarthrosis of knee

2.5

170.4

1192

5054

A10BG02

ATC

rosiglitazone; oral

6.4

170.0

284

451

P01AB01

ATC

metronidazole; oral, rectal

1.5

169.6

7545

56992

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

2.0

169.5

2024

10647

A10AD05

ATC

insulin aspart; parenteral

5.7

169.1

320

574

M70.6

ICD-10 Finland

Trochanteric bursitis

1.9

168.4

2456

13826

N05CD07

ATC

temazepam; oral

2.1

167.4

1691

8362

M02AA07

ATC

piroxicam; topical

1.6

167.1

5712

40604

R01AD09

ATC

mometasone; nasal

1.5

166.7

8817

69062

D01AC02

ATC

miconazole; topical

2.3

166.5

1316

5889

R06AE07

ATC

cetirizine; oral

1.5

166.4

8387

65007

R96

ICPC

Asthma

2.0

166.2

1902

9852

N06AX26

ATC

vortioxetine; oral

2.1

165.9

1763

8886

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.9

165.6

2527

14428

R5110, ,

SPAT

2.2

165.6

1463

6859

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

5.0

165.0

361

737

ZXE00

NOMESCO Finland

One hour or less

1.6

164.8

6856

50925

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.5

164.6

1137

4791

ZY010

NOMESCO Finland

Hospital outpatient

2.4

164.4

1181

5065

S29

ICPC

Skin symptom/complaint other

1.7

164.4

3676

23474

SPAT1229

SPAT

Assessment of need for aid

2.4

164.0

1190

5127

40199

ICD-8 Finland

Essential benign hypertension

5.5

163.8

322

598

J01CF05

ATC

flucloxacillin; systemic

2.2

163.5

1442

6754

SPAT1254

SPAT

Administration of medicine

1.9

162.3

2347

13166

WX002

NOMESCO Finland

Sedation and analgesia

1.8

161.3

3080

18807

L30.4

ICD-10 Finland

Erythema intertrigo

4.7

160.5

375

809

O24.1

ICD-10 Finland

Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, non-insulin-dependent

8.0

159.6

216

272

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.6

158.2

4524

30734

J01CE02

ATC

phenoxymethylpenicillin; oral

1.6

158.2

12651

107717

N02AA05

ATC

oxycodone; systemic

1.8

157.9

2648

15550

SFA20

NOMESCO Finland

Two-surface restoration

1.5

157.9

11195

92843

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

3.1

157.7

668

2180

WZC30

NOMESCO Finland

Teaching

1.8

156.8

2865

17258

C07AB02

ATC

metoprolol; systemic

1.8

154.0

2741

16376

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.3

153.2

1261

5735

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

2.6

151.2

886

3447

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.7

150.9

3035

18773

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.8

150.3

2529

14850

N06AX03

ATC

mianserin; oral

2.6

150.0

898

3531

M03BC51

ATC

orphenadrine, combinations; systemic

1.6

150.0

5032

35432

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

3.7

149.6

477

1299

N06AA09

ATC

amitriptyline; systemic

2.1

149.2

1602

8091

M10.0

ICD-10 Finland

Idiopathic gout

3.4

149.2

558

1688

M79.7

ICD-10 Finland

Fibromyalgia

2.7

149.0

871

3385

R53

ICD-10 Finland

Malaise and fatigue

1.6

148.8

4724

32827

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.5

148.4

1025

4314

XA420

NOMESCO Finland

Extensive sleep examination

5.5

148.3

290

536

R03BA01

ATC

beclometasone; inhalant

1.8

148.2

2510

14762

H02AB04

ATC

methylprednisolone; systemic

1.8

147.9

2538

14984

B01AF02

ATC

apixaban; oral

2.0

147.6

1778

9360

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

2.0

146.8

1810

9604

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

2.3

146.8

1142

5068

K80.0

ICD-10 Finland

Calculus of gallbladder with acute cholecystitis

2.7

146.6

799

2996

Z01.8

ICD-10 Finland

Other specified special examinations

1.6

146.6

4088

27521

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.0

146.5

1666

8590

N62

ICD-10 Finland

Hypertrophy of breast

2.5

145.3

973

4036

G63.2*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy

5.7

145.3

270

476

R07.4

ICD-10 Finland

Chest pain, unspecified

1.6

144.0

4544

31489

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

3.5

144.0

505

1466

L16

ICPC

Ankle symptom/complaint

1.8

143.8

2316

13405

ZXE20

NOMESCO Finland

More than three and less than five hours

1.9

143.8

2107

11840

J01FA09

ATC

clarithromycin; systemic

1.5

143.7

5709

41664

A10BD03

ATC

metformin and rosiglitazone; systemic

5.6

143.3

276

503

R51.80

ICD-10 Finland

Headache

1.7

143.3

3207

20393

WX110, ,

SPAT

2.2

142.7

1231

5704

A02BC03

ATC

lansoprazole; oral

1.6

141.7

4603

32094

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.5

141.6

5209

37352

N02BF02

ATC

pregabalin; oral

2.1

140.6

1367

6644

M10

ICD-10 Finland

Gout

2.8

140.5

711

2563

O99.2

ICD-10 Finland

Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium

3.6

140.1

469

1320

SGA02

NOMESCO Finland

Opening and preparing the root canals

1.8

139.1

2442

14495

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.5

138.7

948

3969

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.7

138.3

787

3016

R05FA02

ATC

opium derivatives and expectorants; systemic

1.5

138.2

6679

50687

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.9

138.1

2028

11395

B01AB10

ATC

tinzaparin; parenteral

1.9

138.0

1946

10791

SAA01

NOMESCO Finland

Simple examination of mouth

1.5

137.4

13626

119324

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.5

137.3

10385

86060

EB1AA, ,

SPAT

2.1

137.2

1348

6576

N05AX08

ATC

risperidone; systemic

2.1

137.2

1345

6556

ZXA05

NOMESCO Finland

Left side

1.6

137.0

3641

24166

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.6

136.9

4426

30783

D07AC01

ATC

betamethasone; topical

1.5

136.5

6329

47595

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

3.9

136.0

414

1092

SFA10

NOMESCO Finland

One-surface restoration

1.5

135.8

10302

85334

M54

ICD-10 Finland

Dorsalgia

1.8

135.6

2562

15528

SPAT1310

SPAT

Counselling related to known health issue

1.5

135.4

5258

38077

OAB50, ,

SPAT

2.1

133.8

1384

6882

H3601, E113,

ICD-10 Finland

5.2

133.7

278

543

M01AH01

ATC

celecoxib; oral

1.7

133.3

2922

18441

L60.0

ICD-10 Finland

Ingrowing nail

2.4

133.0

964

4143

C09CA03

ATC

valsartan; oral

2.1

132.5

1408

7073

A06AC01

ATC

ispaghula (psylla seeds); oral

1.6

131.2

4305

29996

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.5

131.1

5073

36660

UJF32

NOMESCO Finland

Coloscopy

1.6

130.9

4074

28040

F50.3

ICD-10 Finland

Atypical bulimia nervosa

6.6

130.8

210

320

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.5

130.7

5569

41064

C08CA02

ATC

felodipine; oral

2.1

130.6

1264

6127

A97

ICPC

No disease

1.6

130.0

3532

23532

F32.1

ICD-10 Finland

Moderate depressive episode

2.0

129.4

1432

7298

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.0

129.2

1640

8771

R05

ICPC

Cough

1.5

128.4

4547

32203

TLC00

NOMESCO Finland

Insertion of intrauterine device

2.0

127.8

1579

8366

N05AN01

ATC

lithium; oral

3.1

127.7

553

1827

P99

ICPC

Psychological disorders other

2.7

127.3

729

2801

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.0

126.8

1445

7441

CL2S4, ,

SPAT

3.3

126.5

484

1484

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.9

126.5

1833

10238

SPAT1240

SPAT

Therapeutic discussion

1.8

126.3

2159

12689

C01DA14

ATC

isosorbide mononitrate; oral

1.9

126.2

1661

8991

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

2.6

125.9

753

2956

LCA06

NOMESCO Finland

Biopsy of endometrium

1.7

125.8

2393

14505

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

2.0

125.7

1502

7864

R03AC12

ATC

salmeterol; inhalant

2.6

125.6

752

2954

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.7

124.6

2591

16097

F32

ICD-10 Finland

Depressive episode

2.1

124.5

1255

6175

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.7

124.4

2968

19117

A04

ICPC

Weakness/tiredness general

1.7

123.7

2846

18157

E0000UV, ,

ATC

1.5

123.6

7461

58766

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.8

123.4

1915

10927

L73.2

ICD-10 Finland

Hidradenitis suppurativa

4.3

123.0

326

777

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.8

122.6

658

2445

JAD30

NOMESCO Finland

Repair of incisional hernia using prosthetic material

4.0

122.4

354

900

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.3

122.2

955

4239

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

2.5

122.2

785

3190

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

6.0

121.9

217

367

SPAT1255

SPAT

Intravenous administration of medicine

2.2

121.5

1106

5229

X59

ICD-10 Finland

Exposure to unspecified factor

1.6

121.5

3346

22323

A10BH02

ATC

vildagliptin; oral

4.3

121.1

321

765

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.8

121.0

1963

11348

JDF97

NOMESCO Finland

Other laparoscopic bariatric operation on stomach

+∞

120.9

116

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.7

120.9

2728

17307

N06AX05

ATC

trazodone; oral

3.0

120.4

562

1937

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

2.1

120.3

1182

5758

A02BC05

ATC

esomeprazole; systemic

1.5

119.9

6873

53512

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

2.0

119.6

1482

7854

RD160, ,

NOMESCO Finland

15.4

119.5

104

K08.3

ICD-10 Finland

Retained dental root

2.0

119.3

1312

6666

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.7

119.1

2372

14547

C01AA05

ATC

digoxin; systemic

2.4

118.5

857

3677

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.1

118.5

1250

6254

A10BX09

ATC

[U] dapagliflozin

6.0

118.4

210

354

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.7

118.3

680

2617

L14

ICPC

Leg/thigh symptom/complaint

2.0

118.0

1446

7633

SPAT1263

SPAT

Sampling

1.4

117.9

7042

55201

SPAT1249

SPAT

Treatment-related counselling outside office

1.5

117.3

6684

51924

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.7

116.8

2297

14033

P29

ICPC

Psychological sympt/compl other

1.9

116.8

1655

9168

Z35.8

ICD-10 Finland

Supervision of other high-risk pregnancies

1.8

116.6

1872

10781

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.1

116.3

1235

6193

M01AX05

ATC

glucosamine; oral

1.7

116.2

2414

14970

H01

ICPC

Ear pain/earache

1.7

116.0

2340

14395

SGB10

NOMESCO Finland

Root filling of tooth with one root canal

1.7

115.3

2169

13083

J01CA04

ATC

amoxicillin; systemic

1.6

115.3

15040

136199

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

3.2

115.2

471

1504

R74

ICPC

Upper respiratory infection acute

1.4

114.7

6778

52950

IGY02

NOMESCO Finland

Psychiatric monitoring contact

2.5

114.7

723

2911

F31.8

ICD-10 Finland

Other bipolar affective disorders

3.1

114.5

479

1550

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

2.3

114.3

917

4114

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.2

114.3

1065

5079

R06.2

ICD-10 Finland

Wheezing

2.3

114.0

866

3795

O13

ICD-10 Finland

Gestational [pregnancy-induced] hypertension

2.2

113.9

983

4546

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.6

113.4

659

2550

K04.4

ICD-10 Finland

Acute apical periodontitis of pulpal origin

1.8

113.2

1819

10474

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.4

113.1

849

3702

SPAT1283

SPAT

Restricted health certificate

1.6

112.8

3715

25776

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.8

112.7

1784

10225

N05AF03

ATC

chlorprothixene; systemic

2.9

112.6

535

1862

M01AB01

ATC

indometacin; systemic, rectal

2.2

112.5

980

4549

TQW11

NOMESCO Finland

Vacuum treatment of wound

3.4

112.2

411

1226

W85

ICPC

Gestational diabetes

2.3

112.1

933

4251

D64.9

ICD-10 Finland

Anaemia, unspecified

1.9

111.9

1502

8169

SFA40

NOMESCO Finland

Restoration involving the entire crown of the tooth

1.6

111.9

3667

25410

O36.6

ICD-10 Finland

Maternal care for excessive fetal growth

2.4

111.1

791

3368

JAF30

NOMESCO Finland

Repair of umbilical hernia using prosthetic material

3.2

110.8

451

1436

SPAT1301

SPAT

No procedures

1.5

110.6

4905

36205

SPAT1211

SPAT

Application of soft bandage

2.0

109.9

1378

7324

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.6

109.9

2731

17720

WX320

NOMESCO Finland

Spinalanesthesy

1.5

109.5

3905

27544

F50.4

ICD-10 Finland

Overeating associated with other psychological disturbances

30.1

109.3

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.6

109.3

3091

20693

RK320, ,

NOMESCO Finland

6.3

109.2

185

298

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

2.4

109.2

785

3357

M01AC06

ATC

meloxicam; systemic, rectal

1.4

109.2

5877

45012

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.5

108.5

4677

34304

R03AC13

ATC

formoterol; inhalant

2.3

108.5

870

3902

R73.0

ICD-10 Finland

Abnormal glucose tolerance test

3.1

108.2

470

1555

F61.0

ICD-10 Finland

Mixed personality disorders

3.3

108.1

417

1285

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

2.7

108.0

617

2366

JAH01

NOMESCO Finland

Laparoscopy

2.2

108.0

984

4650

I83.1

ICD-10 Finland

Varicose veins of lower extremities with inflammation

3.4

108.0

392

1163

C07AG02

ATC

carvedilol; oral

2.4

107.8

781

3352

K43.0

ICD-10 Finland

Incisional hernia with obstruction, without gangrene

5.3

107.8

220

423

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.7

107.7

2071

12554

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

2.3

107.6

831

3667

J45.8

ICD-10 Finland

Mixed asthma

2.7

107.6

592

2228

S21

ICPC

Skin texture symptom/complaint

1.6

107.4

2561

16437

R73.9

ICD-10 Finland

Hyperglycaemia, unspecified

2.8

106.8

544

1966

C02EA02, ,

ATC

2.9

106.6

503

1744

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.7

106.6

2266

14115

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.8

106.5

1678

9597

WZA90

NOMESCO Finland

Other medical or dental certificate

1.5

105.8

4109

29480

R11

ICD-10 Finland

Nausea and vomiting

1.9

105.7

1576

8859

A03

ICPC

Fever

1.6

105.7

3370

23171

L68.0

ICD-10 Finland

Hirsutism

5.1

105.4

221

435

A08AA04

ATC

dexfenfluramine; oral

14.2

104.7

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

2.1

104.6

1014

4908

J01FA10

ATC

azithromycin; systemic

1.4

104.6

10650

90974

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

3.3

104.5

397

1212

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

3.5

104.4

366

1062

Z01.7

ICD-10 Finland

Laboratory examination

1.6

104.2

3031

20401

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.4

104.1

7407

59504

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.6

103.8

2502

16090

SPAT1298

SPAT

Other function in accordance with nutritional therapy nomenclature

4.6

103.8

246

537

M01AX17

ATC

nimesulide; oral

1.5

103.4

3453

23969

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

2.7

103.4

561

2096

ACC59

NOMESCO Finland

Decompression and freeing of adhesions of peripheral nerve: other or unspecified

2.4

103.1

749

3217

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

2.7

102.7

560

2097

N05CF02

ATC

zolpidem; oral

1.6

102.7

3083

20895

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.8

102.7

1538

8656

N05AH03

ATC

olanzapine; systemic

2.0

102.4

1178

6072

J01MA14

ATC

moxifloxacin; systemic

1.9

102.3

1465

8128

K91.1

ICD-10 Finland

Postgastric surgery syndromes

19.1

102.3

K85

ICPC

Elevated blood pressure

1.7

102.2

2381

15175

K04.1

ICD-10 Finland

Necrosis of pulp

1.7

102.0

2080

12802

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.8

101.9

1805

10680

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.4

101.9

722

3067

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

3.1

101.5

437

1438

K04.09

ICD-10 Finland

Pulpit UNS

2.1

101.2

992

4820

SGA03

NOMESCO Finland

Opening and preparing the root canals, complicated

1.7

101.2

1867

11177

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.8

101.1

1528

8621

J01DA06

ATC

[U] cefuroxime

1.6

101.0

2430

15612

L02

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle

2.3

100.9

805

3601

F51.0

ICD-10 Finland

Nonorganic insomnia

1.5

100.7

3455

24110

TPH07

NOMESCO Finland

Cathetrisation of artery

1.8

100.2

1637

9456

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

2.5

100.2

674

2796

N05AB03

ATC

perphenazine; systemic, rectal

2.5

99.6

631

2545

R50.9

ICD-10 Finland

Fever, unspecified

1.6

99.6

2541

16561

B01AF01

ATC

rivaroxaban; oral

1.8

99.0

1680

9815

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

4.1

98.9

270

658

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.9

98.7

1288

6930

I83.2

ICD-10 Finland

Varicose veins of lower extremities with both ulcer and inflammation

6.4

98.7

163

256

A99

ICPC

Disease/condition unspecnature/site

1.8

98.6

1767

10487

C09DA03

ATC

valsartan and diuretics; oral

2.4

98.4

703

2997

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

3.5

98.3

347

1011

A08AA01

ATC

phentermine; oral

8.5

98.1

126

149

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.4

97.9

704

3010

A41.9

ICD-10 Finland

Sepsis, unspecified

2.7

97.7

537

2019

T45

ICPC

Metabolic, Observ/health educat/advice/diet

3.9

97.7

287

738

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

2.7

97.5

528

1970

201

Kela drug reimbursment

Chronic cardiac insufficiency

2.4

97.2

684

2896

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.5

96.4

3738

26729

R52.9

ICD-10 Finland

Pain, unspecified

1.7

96.2

1874

11379

D07BC01

ATC

betamethasone and antiseptics; topical

1.7

95.8

1922

11764

J01DA09

ATC

[U] cefadroxil

1.5

95.8

4551

33869

P01

ICPC

Feeling anxious/nervous/tense

1.6

95.5

2741

18354

I50.1

ICD-10 Finland

Left ventricular failure

2.6

95.4

589

2346

L08

ICPC

Shoulder symptom/complaint

1.5

95.4

3860

27835

L02.9

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle, unspecified

2.4

95.1

674

2862

U04

ICPC

Incontinence urine

2.2

95.1

849

3977

Z2445

NOMESCO Finland

Psychologist

2.3

95.0

779

3524

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.6

94.7

2377

15414

A29

ICPC

General symptom/complaint other

1.7

94.6

2142

13536

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

3.2

94.5

380

1201

SGC00

NOMESCO Finland

Medication, disinfection of root canals

1.7

94.4

2033

12679

SGC10

NOMESCO Finland

Pulp capping

1.8

94.3

1703

10123

EBA30

NOMESCO Finland

Extraction of root of tooth

2.1

94.0

918

4452

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

4.2

94.0

253

610

AA1AD

NOMESCO Finland

CT of head and brain

1.5

93.6

4036

29457

M72.2

ICD-10 Finland

Plantar fascial fibromatosis

1.8

93.5

1615

9477

W84

ICPC

Pregnancy high risk

2.2

92.7

798

3683

N47

ICD-10 Finland

Redundant prepuce, phimosis and paraphimosis

2.8

92.6

467

1679

E000001, ,

ATC

1.5

92.4

3372

23787

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.2

92.3

828

3885

L86

ICPC

Back syndrome with radiating pain

2.0

92.0

1096

5714

RD140, ,

NOMESCO Finland

314.5

91.9

G93.2

ICD-10 Finland

Benign intracranial hypertension

9.5

91.7

108

114

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.6

91.7

2515

16648

IGY99

NOMESCO Finland

Other psychiatric treatment contact

2.8

91.5

484

1784

SPAT1260

SPAT

Consultation of another employee

1.6

91.5

2727

18402

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

2.6

91.2

541

2113

G44.2

ICD-10 Finland

Tension-type headache

1.6

91.1

2622

17550

N03AG01

ATC

valproic acid; systemic, rectal

2.0

91.1

1051

5419

R42

ICD-10 Finland

Dizziness and giddiness

1.5

91.0

3578

25616

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.6

91.0

2196

14092

Z98.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

6161

38843

1.88

323.01

2.5

2.3

—

(3002032) Base excess in Venous blood by calculation

2722

12780

2.33

317.66

4.8

4.0

1.99

1.73

mmol/l

2.53

2441

11246

(40768797) Stomach Pathology biopsy report

3943

21461

2.07

316.96

1.2

—

(3012544) pH of Venous blood

2797

13320

2.30

315.53

4.8

4.0

7.37

7.38

1.88

1550

7460

(3002582) Erythrocytes [#/volume] in Urine

7288

48764

1.82

312.86

3.7

3.2

49.35

62.35

e6/l

0.72

5460

36664

(3027801) Oxygen [Partial pressure] in Arterial blood

3075

15298

2.21

311.72

9.4

7.9

11.34

13.15

kpa

75.60

2962

14773

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

3076

15305

2.21

311.72

9.4

7.9

5.32

5.05

kpa

35.41

2971

14780

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

1955

7954

2.63

311.16

4.1

3.3

5.31

5.09

kpa

21.08

1887

7618

(3018418) pH of Serum or Plasma

7300

43807

2.10

307.65

4.7

4.1

7.40

0.12

4951

30895

(3012516) Albumin [Mass/volume] in Urine

8337

42514

2.75

307.65

4.0

3.5

60.02

46.72

mg/l

4.07

5999

26318

(3013826) Glucose [Moles/volume] in Serum or Plasma

12625

88764

2.34

307.65

6.7

4.7

6.98

6.49

mmol/l

95.47

12112

83102

(3026493) Urate [Moles/volume] in Serum or Plasma

7541

39425

2.54

307.65

2.8

2.4

357.39

322.41

umol/l

154.29

6792

35538

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

3043

13521

2.50

307.65

2.4

0.21

0.22

g/l

2.32

2869

12697

(3036481) Cortisol [Moles/volume] in Serum or Plasma

3289

15403

2.38

307.65

2.1

2.3

339.79

383.50

nmol/l

29.81

2985

14431

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

15111

119597

2.46

307.65

9.3

8.0

82.11

75.90

u/l

48.52

14642

114080

(3024561) Albumin [Mass/volume] in Serum or Plasma

11604

65522

3.08

307.65

5.9

4.9

35.78

36.42

g/l

33.78

11181

61659

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

10251

64774

2.31

307.65

8.2

6.3

1.21

mmol/l

12.11

9769

60416

(3012095) Magnesium [Moles/volume] in Serum or Plasma

5780

23557

3.12

307.65

3.2

3.5

0.82

mmol/l

0.35

5537

22276

(3021960) Folate [Moles/volume] in Serum or Plasma

7360

39675

2.42

307.65

2.1

1.6

21.01

20.22

nmol/l

4.93

6747

34388

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

5060

29803

1.96

307.65

2.2

1.6

11487500.32

37969859.87

pmol/l

5.16

4492

25510

(3007853) Bacteria identified in Skin by Aerobe culture

3856

18154

2.42

307.65

2.1

1.7

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

5096

17435

3.66

307.65

5.4

6.2

1.07

1.03

mmol/l

20.00

4900

16238

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

10990

64296

2.76

307.65

2.9

1.9

94.11

97.80

pmol/l

15.28

6845

34147

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

16969

146717

2.97

307.65

10.0

5.2

41.35

38.01

mmol/mol

314.90

16462

139372

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

4322

21170

2.36

307.65

3.0

2.6

20.90

23.74

37.89

4086

19773

(3042936) Bacteria identified in Isolate by Culture

4013

20961

2.17

307.65

2.5

2.0

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

6080

36734

1.98

307.65

2.1

1.8

1.01

1.08

mg/l

0.93

4850

28071

(3009508) Creatinine [Moles/volume] in Urine

9056

48312

2.72

307.65

3.9

3.4

8.02

7.70

mmol/l

8.22

7916

41807

(3019309) Folate [Moles/volume] in Red Blood Cells

4825

20872

2.78

307.65

2.2

1.7

1200.96

1161.42

nmol/l

2.33

4085

16083

(3023368) Bacteria identified in Blood by Culture

6501

37348

2.14

307.65

5.0

4.1

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

11907

85859

2.09

307.65

4.7

3.1

96.06

101.56

ug/l

2.08

11399

81519

(3015377) Calcium [Moles/volume] in Serum or Plasma

8072

52114

1.98

307.65

3.1

3.5

2.34

2.35

mmol/l

16.45

7463

47983

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

6740

35859

2.39

307.65

3.6

2.9

1048.16

1085.61

ng/l

0.33

5634

30395

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

11188

72972

2.36

307.65

8.7

6.9

1.21

mmol/l

19.15

10168

63429

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

7446

39269

2.50

307.65

2.9

2.2

3.04

2.65

mg/l

33.06

6728

34103

(3044640) Blood type and Crossmatch panel - Blood

7948

51583

1.95

307.65

2.6

2.3

—

(3032080) INR in Blood by Coagulation assay

9566

63799

2.04

307.65

16.2

11.4

1.23

1.18

inr

14.28

7873

52886

(3022948) Iron [Moles/volume] in Serum or Plasma

4990

25289

2.33

307.65

3.0

2.5

12.71

14.01

umol/l

30.23

4731

23745

(3016244) Insulin [Units/volume] in Serum or Plasma

827

745

11.57

307.65

4.5

2.6

37.63

16.28

mu/l

29.89

803

690

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

9194

55005

2.34

307.65

3.5

3.3

30.99

32.48

u/l

1.50

8786

52324

(3020682) Albumin/Creatinine [Ratio] in Urine

8479

43135

2.79

307.65

4.7

4.1

10.64

8.45

mg/mmol

3.04

5934

26375

(3021447) Carbon dioxide [Partial pressure] in Venous blood

2804

13138

2.34

307.65

4.8

4.0

5.98

5.80

kpa

13.65

2739

12823

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

11510

73432

2.51

307.65

3.8

2.4

69.96

1278.98

nmol/l

0.50

10947

68204

(3033658) Prothrombin time (PT) actual/Normal

6789

39314

2.15

307.65

4.7

4.0

93.32

93.23

0.11

6610

38360

(3004789) Transferrin [Mass/volume] in Serum or Plasma

4674

23368

2.34

307.65

2.9

2.5

2.49

2.37

g/l

39.20

4374

21692

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

11780

80336

2.29

307.65

6.2

6.4

10.68

10.82

umol/l

0.61

11320

76512

(3019977) pH of Arterial blood

3066

15323

2.20

306.88

9.4

8.0

7.41

7.42

13.77

1627

8203

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

15450

130526

2.14

306.78

5.8

4.5

14.54

14.53

pmol/l

0.32

14720

122250

(3009343) pH of Capillary blood

1904

7698

2.64

306.72

4.0

3.3

7.41

7.42

8.23

1578

6387

(3030467) Casts [#/volume] in Urine by Automated count

6478

42054

1.83

305.27

3.5

3.1

0.48

0.36

e6/l

3.49

4662

30178

(3003396) Base excess in Arterial blood by calculation

3042

15185

2.20

305.24

9.4

7.9

1.18

0.78

mmol/l

5.67

2593

12460

(3000991) Gas panel - Venous blood

2538

11799

2.33

302.00

10.9

9.3

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

10252

76421

1.77

299.54

3.1

2.7

—

estimate

—

(3018095) Leukocytes [#/volume] in Urine

8282

58170

1.77

296.82

4.5

3.7

84.41

86.60

e6/l

0.10

5686

39620

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

261

178

14.86

293.52

1.0

1.1

70.92

86.83

ug/l

5.04

231

132

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

7298

49548

1.78

292.91

3.0

2.6

51.10

64.98

u/l

6.08

6853

46222

(3024354) Oxygen [Partial pressure] in Venous blood

2364

10890

2.34

286.34

4.0

3.3

4.79

4.61

kpa

3.56

2304

10607

(3006315) Basophils [#/volume] in Blood

10917

83521

1.75

284.62

7.2

6.4

0.04

e9/l

1.65

9336

72846

(3014111) Lactate [Moles/volume] in Serum or Plasma

2568

12325

2.26

282.05

9.5

7.9

1.35

1.29

mmol/l

2.37

2522

12119

(3001604) Monocytes [#/volume] in Blood

10887

83372

1.75

281.36

7.1

6.4

0.59

0.56

e9/l

28.22

9328

72764

(3013650) Neutrophils [#/volume] in Blood by Automated count

11845

93055

1.76

278.06

10.0

9.6

4.57

3.98

e9/l

142.04

10149

81373

(3019198) Lymphocytes [#/volume] in Blood

11081

85502

1.74

276.46

7.2

6.4

2.02

1.92

e9/l

11.07

9731

76312

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

1665

6663

2.65

272.52

3.9

3.2

1.98

1.63

mmol/l

2.98

1260

4805

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

4694

28399

1.88

271.00

2.7

2.9

2.44

mmol/l

0.96

4159

25533

(3013115) Eosinophils [#/volume] in Blood

11117

86277

1.73

267.32

7.6

6.5

0.20

0.19

e9/l

20.47

9733

76471

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

671

1551

4.45

264.04

1.2

22.40

35.81

nmol/l

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

3361

18370

2.01

261.35

2.6

2.7

7.56

7.75

umol/l

0.20

2857

15938

(3016502) Oxygen saturation in Arterial blood

2687

13529

2.15

260.44

9.8

8.3

94.89

96.00

16.06

2621

13066

(36304419) Bacteria [Presence] in Urine

6107

40503

1.76

257.34

3.5

3.0

28.06

129.65

estimate

0.48

130

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

4351

26260

1.86

250.04

3.1

2.8

1.30

1.17

e6/l

0.47

2174

13586

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

1802

7858

2.43

245.07

11.2

10.2

24.71

24.16

mmol/l

9.08

1755

7740

(3044889) 12 lead EKG panel

13120

107858

1.75

243.91

4.4

3.5

5223.07

3576.99

0.11

189

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

2221

10620

2.24

243.87

4.4

3.9

98.02

83.94

ng/l

8.73

2010

9395

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

2879

15231

2.05

243.45

2.6

2.5

57.53

40.43

u/l

0.48

2390

13060

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

16836

150714

2.35

233.85

7.1

4.4

6.29

5.74

mmol/l

307.65

16114

141397

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

4000

24016

1.85

231.18

3.2

2.9

5.31

3.15

e6/l

12.86

1826

11292

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

3831

22765

1.86

228.49

2.1

1.9

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

863

2639

3.38

227.64

2.2

2.4

1.04

0.82

nmol/l

11.75

712

2284

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

16830

151034

2.32

225.52

7.4

5.3

1.81

mu/l

0.08

16178

142635

(3020779) Urea [Moles/volume] in Serum or Plasma

2332

11773

2.12

221.97

8.6

7.8

10.49

8.69

mmol/l

22.92

2248

11329

(42870588) Differential panel, method unspecified - Blood

7425

53489

1.65

221.06

6.8

6.5

—

4.61

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

571

1338

4.37

220.52

1.6

1.3

1.66

1.45

nmol/l

3.51

528

1196

(3031040) Bacteria [#/volume] in Urine by Automated count

12726

105050

1.68

218.42

5.7

4.3

1778.55

1876.83

e6/l

0.06

146

1246

(3011397) Hemoglobin [Presence] in Urine by Test strip

5785

39286

1.69

214.91

4.4

3.6

0.17

0.40

0.66

317

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

2970

16566

1.95

213.56

1.9

1.8

—

(3015736) pH of Urine

9181

70138

1.62

212.63

4.1

3.2

6.16

6.22

4.78

4826

39918

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

1739

7950

2.31

211.06

5.0

4.2

24.43

24.19

mmol/l

2.11

1716

7866

(3037467) Urinalysis macro (dipstick) panel - Urine

13183

110337

1.68

209.22

5.3

4.3

1.56

5.81

0.66

146

(3019069) Monocytes/Leukocytes in Blood

9809

76375

1.61

208.07

7.3

6.6

8.18

8.62

58.18

9300

72147

(3014007) Fractional oxyhemoglobin in Arterial blood

1864

8824

2.24

207.98

11.6

10.2

93.32

94.20

8.18

1858

8798

(3006504) Eosinophils/Leukocytes in Blood

9789

76204

1.61

207.63

7.3

6.5

2.78

2.83

1.52

9270

71917

(3022096) Basophils/Leukocytes in Blood

9782

76154

1.61

207.29

7.3

6.6

0.65

0.70

20.13

9241

71734

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

1107

4163

2.77

203.06

4.3

3.4

25.02

24.77

mmol/l

2.01

1043

3843

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

3644

22020

1.82

202.82

1.9

1.7

1.43

1.41

1.53

3235

19689

(3018010) Neutrophils/Leukocytes in Blood

9877

77412

1.59

200.68

7.2

6.3

58.63

56.62

67.79

9497

74358

(3019550) Sodium [Moles/volume] in Serum or Plasma

17352

159044

2.56

199.84

26.5

14.8

139.77

139.67

mmol/l

7.54

17199

155963

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

1842

8828

2.21

198.97

11.6

10.0

1.40

1.34

1.72

1830

8778

(3002030) Lymphocytes/Leukocytes in Blood

10009

78783

1.59

198.94

7.3

6.5

27.28

28.87

48.63

9571

75141

(3002173) Hemoglobin [Mass/volume] in Arterial blood

2424

12908

2.01

198.10

10.7

8.7

123.88

121.36

g/l

7.12

2392

12599

(3023103) Potassium [Moles/volume] in Serum or Plasma

17368

159407

2.55

196.70

26.8

14.9

3.96

3.94

mmol/l

11.14

17208

156006

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

2801

15734

1.92

195.68

2.0

1.8

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

1788

8547

2.21

194.16

11.8

10.3

0.61

0.65

4.30

1777

8500

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

7356

54188

1.59

191.52

4.4

3.2

42.82

54.33

ng/l

0.46

4684

31763

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

13703

116861

1.67

191.41

4.3

3.1

51.53

41.08

u/l

29.97

13117

111576

(3021589) Normoblasts [#/volume] in Blood

9303

72472

1.57

189.49

12.6

10.4

0.00

e9/l

1.90

7340

59200

(3000850) Epithelial cells [#/volume] in Urine

4928

33167

1.66

183.62

2.9

2.6

7.79

6.13

e6/l

12.54

4463

30138

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

1504

6874

2.29

181.58

3.8

3.1

0.62

0.10

1498

6848

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

1516

6953

2.29

181.52

3.8

3.1

1.40

1.28

3.23

1509

6915

(3015235) Bicarbonate [Moles/volume] in Capillary blood

1065

4200

2.63

177.39

2.9

2.7

25.13

24.53

mmol/l

4.86

1050

4129

(3026782) Osmolality of Urine

4252

27745

1.69

177.29

3.1

2.8

556.77

524.68

mosm/kgh2o

15.15

3699

24336

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

777

2641

3.03

171.16

2.3

2.4

113.17

97.06

ug/min

0.40

470

1625

(40758558) Short blood count panel - Blood

6593

48317

1.57

169.63

6.9

6.2

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

1655

8096

2.15

168.50

4.2

3.3

130.54

130.06

g/l

0.36

1613

7893

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

8622

67200

1.53

166.88

2.1

1.9

1.58

1.33

mmol/l

105.17

7564

58108

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

4142

27279

1.67

164.91

4.1

3.5

241.81

426.40

ng/l

2.30

2926

18688

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

1445

6780

2.23

163.16

2.3

1.7

5.20

3.96

mg/l

2.65

1364

4754

(3009261) Glucose [Presence] in Urine by Test strip

10769

88396

1.52

160.93

4.6

3.6

0.57

0.21

estimate

0.29

1846

17285

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

6183

45065

1.56

160.76

2.3

2.2

192.62

186.42

u/l

0.21

5897

42871

(3035350) Ketones [Presence] in Urine by Test strip

10703

87799

1.52

159.94

4.6

3.6

5.12

3.77

estimate

0.30

2024

17964

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

1358

6266

2.26

159.59

4.8

3.8

50.80

48.61

2.50

1340

6177

(3021601) Nitrite [Presence] in Urine by Test strip

10608

86890

1.52

159.37

4.6

3.6

0.00

estimate

0.68

1986

17716

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

13800

119925

1.60

157.19

5.0

4.2

15.49

10.30

mm/h

287.73

13129

113639

(3013139) Helicobacter pylori Ag [Presence] in Stool

2144

11869

1.91

153.81

1.2

—

(3020891) Body temperature

1306

6034

2.25

152.79

5.3

4.6

36.93

36.91

°c

1.65

1291

5993

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

1785

9328

2.01

151.44

2.9

2.8

140.25

161.90

ng/l

2.07

1545

8476

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

16382

149509

1.86

148.79

5.3

3.9

1.55

1.24

mmol/l

307.65

15612

140949

(44816559) Phosphatidylethanol [Mass/volume] in Blood

1467

7175

2.13

148.71

1.7

0.28

0.32

mg/l

1.79

608

3393

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1557

7810

2.09

147.64

1.9

1.6

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1903

10360

1.93

142.98

1.7

—

(3027945) Reticulocytes/Erythrocytes in Blood

2522

15054

1.78

141.13

2.4

2.6

1.96

1.75

18.18

2254

13575

(3010015) Selenium [Moles/volume] in Serum or Plasma

153

151

10.21

136.44

2.2

1.6

1.32

1.36

umol/l

0.61

146

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1715

9179

1.96

135.12

9.6

8.2

25.31

24.70

mmol/l

7.81

1701

9129

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

16548

152621

1.82

129.45

20.5

12.7

88.06

86.37

ml/min/173m2

18.66

15660

139917

(3027273) Bicarbonate [Moles/volume] in Venous blood

1163

5541

2.17

125.43

4.0

3.4

25.40

25.23

mmol/l

0.90

1136

5354

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

5726

42846

1.49

123.49

1.4

1.3

1.52

1.60

u/ml

0.18

1478

12553

(3007164) IgA [Mass/volume] in Serum or Plasma

5044

36818

1.51

122.63

1.5

2.54

2.25

g/l

17.75

3036

23982

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

17139

160263

1.99

122.50

22.8

13.6

22.34

22.11

mg/l

0.46

15896

128936

(3003129) Base excess in Capillary blood by calculation

448

1351

3.37

120.27

2.1

2.2

0.97

0.51

mmol/l

1.73

434

1280

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

886

3839

2.37

119.82

3.3

3.4

0.35

iu/ml

0.09

463

2075

(3037522) Nuclear Ab [Titer] in Serum

3728

25677

1.57

117.61

1.4

495.36

535.32

titre

0.61

690

5403

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

17071

159796

1.93

115.83

7.2

5.1

2.63

2.81

mmol/l

151.25

16449

151664

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

1986

11741

1.77

113.13

1.6

1.5

—

(3028717) Thiamine [Mass/volume] in Blood

148

179

8.33

113.08

1.4

1.1

62.72

61.95

ug/l

0.16

148

179

(3000494) Fungus identified in Specimen by Culture

2969

19559

1.62

112.60

1.6

1.5

—

(3018405) Lactate [Moles/volume] in Arterial blood

902

4092

2.27

109.45

4.4

4.0

1.40

1.37

mmol/l

0.28

884

4018

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

16851

157578

1.81

107.77

6.2

4.5

1.30

1.51

mmol/l

307.65

16195

149548

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

16911

158318

1.83

107.59

6.3

4.6

4.43

4.76

mmol/l

307.65

16332

150851

(3013512) EKG study

6095

47320

1.43

103.85

4.1

3.1

0.64

0.75

0.32

109

(3018677) aPTT in Platelet poor plasma by Coagulation assay

3205

21925

1.56

102.41

2.2

29.88

29.34

5.11

3133

21317

(4146454) Self-monitoring of blood glucose

371

1106

3.40

101.42

2.8

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

621

2473

2.56

100.65

1.1

41.45

5193.00

iu/ml

0.67

142

535

(3034770) Mitochondria Ab [Titer] in Serum

968

4694

2.12

99.28

1.2

1.3

1150.77

940.00

titre

0.19

146

(3023520) Reticulocytes [#/volume] in Blood

1880

11345

1.73

98.88

2.4

2.6

79.40

69.43

e9/l

20.36

1323

8204

(3001186) Copper [Moles/volume] in Serum or Plasma

215

439

4.94

98.31

1.9

1.2

17.28

16.58

umol/l

1.18

203

369

(3008152) Bicarbonate [Moles/volume] in Arterial blood

1436

8042

1.85

97.17

8.1

6.8

24.87

24.41

mmol/l

4.22

1390

7686

(3020630) Protein [Mass/volume] in Serum or Plasma

1812

10938

1.73

95.00

1.9

2.6

66.50

66.67

g/l

0.44

1699

10120

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

821

3853

2.18

91.44

1.3

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

2417

15888

1.60

90.71

3.7

4.6

230.32

237.97

u/l

1.94

2297

15174

(3024928) Oxygen saturation in Venous blood

762

3487

2.24

90.32

4.1

3.3

65.85

62.43

4.00

730

3387

(3027923) C peptide [Moles/volume] in Serum or Plasma

272

715

3.85

89.78

2.1

1.5

1.62

1.14

nmol/l

6.34

202

543

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

4265

31784

1.44

87.78

1.4

1.3

9.01

10.27

u/ml

0.66

1679

13344

(3020717) Zinc [Moles/volume] in Serum or Plasma

324

972

3.37

87.71

1.8

1.4

15.08

26.50

umol/l

14.55

310

901

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

4588

34661

1.43

87.64

1.4

1.3

26.85

30.97

iu/ml

0.98

1198

10567

(3007566) Smooth muscle Ab [Titer] in Serum

949

4782

2.04

87.61

1.2

1.3

115.18

132.05

titre

0.28

488

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

956

4848

2.03

86.70

2.2

1.9

1.68

2.11

ug/l

0.76

855

4326

(3017143) Hepatitis C virus Ab [Presence] in Serum

3219

22771

1.50

86.29

1.8

1.7

—

(3052851) Hemolysis interference index of Serum or Plasma

832

4015

2.12

86.23

3.1

3.0

1.99

2.14

index

0.24

422

2061

(3028707) Methadone [Presence] in Urine by Screen method

774

3660

2.16

84.50

2.3

2.7

—

(3028626) Oxygen [Partial pressure] in Capillary blood

681

3063

2.27

84.10

3.1

3.0

8.30

8.44

kpa

1.50

673

2993

(3020911) Cortisol [Moles/time] in 24 hour Urine

233

576

4.08

83.77

1.5

153.15

218.00

nmol/24h

0.32

233

576

(3009214) Lutropin [Units/volume] in Serum or Plasma

1096

5917

1.91

82.76

1.4

1.3

8.98

11.18

u/l

8.07

881

4816

(3043409) Potassium [Moles/volume] in Arterial blood

741

3485

2.17

81.99

4.8

4.3

3.88

3.85

mmol/l

0.80

734

3454

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

1205

6743

1.84

81.29

1.5

1.7

16.22

13.99

u/ml

0.48

186

1881

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

1895

12038

1.64

81.19

3.1

3.6

4.45

4.54

pmol/l

3.81

1714

10963

(3013005) Retinol [Moles/volume] in Serum or Plasma

277

794

3.53

80.52

1.8

1.7

1.88

1.94

umol/l

0.74

263

719

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

614

2726

2.30

78.16

2.0

1.5

—

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

1936

12495

1.61

77.58

3.0

2.6

71.81

71.86

ml/min/173m2

0.02

921

5075

(3028026) IgM [Mass/volume] in Serum or Plasma

1594

9832

1.68

76.35

1.6

1.9

1.14

1.33

g/l

6.47

1490

9152

(3021387) Prolactin [Units/volume] in Serum or Plasma

1385

8263

1.73

74.97

1.8

1.6

299.06

307.14

mu/l

0.43

1230

7445

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

903

4743

1.95

73.87

2.3

450.47

524.39

ug/l

0.44

856

4447

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

586

2613

2.28

73.82

1.4

1.2

—

(3005719) IgG [Mass/volume] in Serum or Plasma

1956

12809

1.59

73.52

2.5

2.9

10.57

10.52

g/l

0.22

1835

11882

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

585

2613

2.28

73.39

1.4

1.2

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1639

10284

1.65

73.36

2.4

2.2

5.89

7.69

ug/l

2.10

1396

9120

(3019150) Specific gravity of Urine by Refractometry

4893

38478

1.37

70.83

4.9

3.7

1.35

1.18

kg/l

0.21

3036

24991

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

1067

6003

1.83

70.49

1.8

1.66

1.46

g/l

9.08

934

5232

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

1316

7878

1.72

70.22

13.3

9.8

16.03

16.09

0.33

1289

7595

(3014051) Protein [Presence] in Urine by Test strip

6055

49392

1.34

68.36

3.2

2.7

0.12

0.06

0.71

836

(3029937) Albumin [Presence] in Urine by Test strip

5734

46500

1.34

67.04

5.1

3.8

0.01

0.00

estimate

0.52

1835

16710

(3024666) Lithium [Moles/volume] in Serum or Plasma

310

1065

2.94

66.82

14.9

12.9

0.62

mmol/l

0.08

287

994

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

4433

34586

1.37

66.67

1.8

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

950

5249

1.85

66.46

1.7

2.3

4.44

4.21

g/l

11.99

889

4858

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

949

5245

1.85

66.32

1.7

2.3

4.00

3.64

g/l

11.80

888

4855

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

950

5255

1.85

66.21

1.7

2.3

7.76

7.22

g/l

18.43

888

4861

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

2323

16154

1.50

65.96

8.6

5.9

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

253

784

3.26

65.09

1.8

1.6

3.09

13.61

nmol/l

0.81

199

652

(3037121) Protein [Mass/volume] in Urine

866

4679

1.89

64.95

3.0

3.3

336.32

407.52

mg/l

0.74

451

2109

(3021901) Oxygen saturation in Capillary blood

550

2525

2.21

64.55

3.1

2.8

90.28

90.93

1.43

541

2464

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

330

1201

2.78

63.96

1.4

1.3

5.50

5.21

umol/l

0.67

301

1062

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

552

2555

2.20

63.49

1.8

1.7

393.05

369.71

mu/l

0.51

456

2062

(3011985) Renin [Units/volume] in Plasma

501

2246

2.26

62.29

1.6

88.09

56.09

mu/l

1.63

456

2044

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

841

4574

1.88

61.76

1.7

2.4

0.39

0.71

g/l

3.84

763

3983

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

855

4686

1.86

61.29

1.9

1.8

34.28

44.46

nmol/l

19.11

834

4597

(3011288) Drugs identified in Urine by Screen method Nominal

1083

6409

1.73

59.98

2.1

2.8

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

1411

8960

1.62

59.70

1.1

1.74

9.77

u/ml

1.16

104

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

134

281

4.80

59.50

1.4

5.31

5.68

nmol/l

0.52

127

268

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

892

5015

1.82

58.88

1.7

2.3

2.96

2.84

g/l

3.37

831

4623

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

769

4136

1.90

58.43

1.4

1.5

15.51

13.53

iu/ml

0.10

(3003694) ABO and Rh group [Type] in Blood

6188

51525

1.30

57.61

1.6

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

1065

6345

1.72

57.52

1.6

9.57

14.70

iu/ml

0.91

175

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

2000

13860

1.50

57.19

3.9

3.0

—

(3023183) Ammonium ion [Moles/volume] in Plasma

586

2897

2.06

56.78

3.7

2.8

35.95

33.70

umol/l

1.15

532

2651

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

746

4011

1.90

56.72

1.7

2.3

0.00

0.02

g/l

3.09

691

3613

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

416

1797

2.35

56.43

7.8

6.4

11.61

mg/l

0.00

390

1681

(3030981) Hyaline casts [#/volume] in Urine by Automated count

1764

11982

1.52

55.43

2.5

2.3

0.48

0.37

e6/l

1.32

1674

11342

(3019225) pH of Specimen

1868

12846

1.51

55.34

4.8

4.0

7.36

7.35

0.96

1544

9158

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

678

3561

1.94

55.32

1.7

2.3

0.00

g/l

-0.00

638

3340

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

813

4535

1.83

55.02

1.6

2.3

9.91

10.12

g/l

0.92

749

4104

(3017446) Testosterone [Moles/volume] in Serum or Plasma

1673

11257

1.53

54.90

2.9

2.2

8.62

12.73

nmol/l

85.67

1509

10268

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

331

1315

2.54

53.93

2.3

2.2

18.40

19.31

nmol/l

1.03

316

1257

(3020564) Creatinine [Moles/volume] in Serum or Plasma

17532

169371

1.72

53.73

28.2

16.7

75.84

72.75

umol/l

17.22

17430

167691

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

810

4557

1.81

53.29

1.2

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

724

3941

1.87

52.96

1.9

1.7

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

811

4589

1.80

52.33

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

812

4598

1.80

52.27

1.2

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

704

3817

1.88

52.13

1.7

2.3

0.00

g/l

0.92

640

3344

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

1057

6452

1.68

52.06

1.4

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

802

4533

1.80

51.94

1.4

280.27

284.82

ug/g

0.24

447

2534

(46235355) HIV 1 and 2 tests - Meaningful Use set

4996

40870

1.31

51.75

2.2

2.1

—

(3000492) Spirometry study

2404

17570

1.42

51.66

1.6

1.5

—

19.73

—

(3000475) Leukocytes [#/volume] in Synovial fluid

662

3539

1.90

51.20

1.7

1.6

15167.23

11674.00

e6/l

0.88

424

2547

(3036489) Thrombin time

1042

6383

1.67

50.61

1.9

2.1

20.35

20.72

1.76

916

5567

(3048689) Calprotectin [Mass/mass] in Stool

3202

24657

1.36

50.17

2.4

2.5

140.82

115.05

ug/g

4.55

2636

19655

(3035637) Corticotropin [Mass/volume] in Plasma

444

2071

2.17

50.11

1.7

1.6

29.56

33.86

ng/l

0.54

444

2064

(1616796) Gas panel - Central venous blood

567

2910

1.98

49.48

3.9

3.3

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

17476

169013

1.66

49.06

15.8

11.0

29.82

25.70

u/l

99.27

17239

165144

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

442

2077

2.16

48.96

1.4

552.93

421.52

pmol/l

0.24

391

1790

(3045414) Leukocytes [Presence] in Urine

2079

14939

1.44

48.85

2.2

2.0

0.00

0.03

estimate

6.41

391

3236

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

221

752

2.96

48.58

2.4

2.2

143.69

137.48

umol/l

0.09

121

363

(3005322) IgE [Units/volume] in Serum or Plasma

1790

12513

1.48

48.56

1.4

1.3

218.82

223.05

u/ml

0.05

1695

11685

(36660697) Celiac disease serology panel - Serum

2055

14765

1.44

48.28

1.2

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

910

5485

1.69

46.93

1.3

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

449

2159

2.11

46.87

6.7

5.6

351.78

371.44

umol/l

1.95

404

1894

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

866

5155

1.71

46.77

2.3

2.6

190.01

181.35

2.19

827

4894

(1001926) Buprenorphine [Presence] in Urine by Screen method

1113

7071

1.61

46.68

2.0

2.1

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

714

4043

1.80

45.92

2.0

3.5

53.16

60.97

mg/l

0.25

614

3458

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

904

5472

1.69

45.87

2.0

2.3

96.29

94.38

1.68

864

5268

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

862

5152

1.71

45.86

2.4

2.7

4.03

3.54

g/l

16.90

819

4904

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

713

4038

1.80

45.83

2.0

3.5

39.68

42.73

mg/l

0.30

611

3462

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

7669

66868

1.25

45.62

4.7

3.5

0.72

0.27

estimate

0.49

1606

14705

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

209

717

2.94

45.30

1.8

27.78

29.13

umol/l

1.32

203

670

(3025941) Bacteria identified in Stool by Culture

1445

9805

1.51

45.23

1.3

1.2

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

477

2409

2.01

43.59

1.3

1.2

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

609

3340

1.85

43.48

2.0

1.8

144.33

194.66

pmol/l

24.43

561

3196

(3021879) Hepatitis B virus core Ab [Presence] in Serum

2082

15288

1.41

42.99

1.5

—

(3008037) Lactate [Moles/volume] in Venous blood

543

2895

1.90

42.34

3.9

2.8

1.59

1.51

mmol/l

0.99

532

2809

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

656

3714

1.79

42.21

1.4

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

12693

117565

1.26

42.03

3.9

3.4

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

1094

7099

1.58

41.86

2.2

2.1

38.85

39.77

u/l

0.77

971

6480

(3020876) Protein [Mass/time] in 24 hour Urine

339

1526

2.24

41.82

2.1

2.5

1.50

1.28

g/24h

0.66

195

882

(3023323) Follitropin [Units/volume] in Serum or Plasma

1917

13938

1.42

41.81

1.4

20.20

27.58

iu/l

28.04

1565

12096

(3006184) Hemoglobin [Mass/volume] in Capillary blood

578

3164

1.85

41.52

2.3

2.1

132.39

130.81

g/l

0.77

399

2439

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

1504

10495

1.47

40.86

2.8

2.3

5182.43

6010.40

u/l

0.59

568

4238

(3022145) Colonoscopy Study observation

2428

18447

1.36

40.60

1.4

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

379

1807

2.12

40.49

3.2

0.80

0.82

nmol/l

0.24

314

1420

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

355

1662

2.16

39.75

1.1

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

804

4902

1.67

39.64

1.3

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

883

5531

1.63

39.14

1.7

1.9

0.26

0.23

g/l

23.55

837

5299

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

629

3599

1.77

39.04

1.9

3.4

2.11

3.35

ratio

1.41

347

2037

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

901

5691

1.61

38.59

1.6

1.9

1.35

1.17

g/l

56.14

862

5470

(3011648) Oxygen content in Venous blood

331

1526

2.19

38.54

2.3

2.4

11.80

10.96

2.90

331

1520

(3016879) Cocaine [Presence] in Urine

1239

8430

1.50

38.08

1.9

2.1

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

160

525

3.07

37.59

1.9

2.1

215.00

87.52

ug/min

0.39

115

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

280

1225

2.31

37.01

1.6

2.0

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

1945

14463

1.39

36.93

1.2

133.44

147.19

u/ml

0.80

674

5741

(3012898) Urea [Moles/volume] in Urine

130

5.48

36.90

1.8

1.5

200.17

164.43

mmol/l

1.45

113

(40768441) Liver Pathology biopsy report

275

1197

2.32

36.79

1.5

1.4

—

(3017569) Oxygen content in Arterial blood

173

604

2.88

36.42

2.2

16.45

15.95

1.07

173

604

(3036603) Volume of Urine

261

1119

2.35

36.16

1.5

1.7

2070.48

2039.72

0.16

256

1101

(3000764) Benzodiazepines [Presence] in Urine

1311

9116

1.47

36.12

1.9

2.0

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

542

3045

1.80

35.80

1.3

1.2

3.57

3.09

u/ml

0.22

176

1161

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

531

2967

1.81

35.71

1.3

4.66

4.06

u/ml

0.38

223

1386

(3002256) Pathology report gross observation

2767

21841

1.31

35.24

1.3

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

419

2183

1.94

35.06

1.2

1.3

34.60

30.74

u/l

0.18

372

1909

(3004716) Salmonella sp identified in Stool by Organism specific culture

1345

9457

1.46

34.95

1.4

—

(3028300) Cannabinoids [Presence] in Urine

1309

9177

1.46

34.53

1.9

2.0

—

(40761511) CBC panel - Blood by Automated count

17170

166558

1.45

34.36

19.5

12.0

—

6.06

—

(3027008) Opiates [Presence] in Urine

1304

9152

1.46

34.19

1.9

2.0

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

335

1628

2.08

34.10

1.2

1.3

—

titre

—

(3010838) Calcium [Moles/time] in 24 hour Urine

512

2884

1.80

33.54

2.0

1.9

5.12

5.19

mmol/24h

0.17

461

2624

(3038515) Glucose [Moles/volume] in Venous blood

438

2354

1.88

33.37

4.3

2.9

7.63

7.42

mmol/l

0.94

430

2289

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1526

11072

1.41

33.33

4.1

3.6

1.22

1.23

mmol/l

6.37

1320

9581

(3027944) Amphetamines [Presence] in Urine

1288

9063

1.45

33.29

1.9

—

(4034850) Laboratory test

754

4737

1.62

32.99

11.4

8.6

—

(3000330) Specific gravity of Urine by Test strip

1037

7004

1.51

32.93

3.5

3.0

1.02

ratio

9.73

914

6210

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

378

1952

1.96

32.49

1.2

1.3

0.15

0.20

nmol/l

2.67

223

1520

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

502

2840

1.79

32.41

1.1

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

452

2480

1.84

32.28

1.2

1.3

—

18.25

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

767

4883

1.60

31.76

1.6

1.5

42.48

62.02

ug/l

54.28

767

4883

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

890

5870

1.54

31.56

6.2

4.8

1.70

1.66

0.38

854

5547

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

282

1324

2.15

31.45

1.2

176.32

217.25

titre

0.31

233

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

508

2911

1.77

31.41

1.1

—

(3010421) pH of Blood

690

4300

1.63

31.20

4.5

3.2

7.41

1.58

678

4252

(3016650) Hepatitis A virus Ab [Presence] in Serum

510

2948

1.75

30.60

1.1

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

830

5428

1.55

30.58

2.1

2.0

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

706

4450

1.61

30.47

2.3

2.2

12.00

11.00

mg/l

2.86

655

4195

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

422

2308

1.85

30.47

1.3

0.15

0.20

nmol/l

1.05

138

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

279

1322

2.13

30.40

1.2

105.71

114.19

titre

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

338

1719

1.98

30.39

1.4

9.85

7.79

mmol/l

11.90

314

1655

(21494755) Public health laboratory ask at order entry panel

1588

21090

0.73

30.38

1.4

1.3

—

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

14559

138484

1.24

30.29

26.8

16.5

13.94

13.44

307.65

14462

136779

(4195642) Thrombophilia screening test

480

2740

1.77

30.08

1.2

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

764

4963

1.56

29.00

2.0

1.9

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

412

2273

1.83

28.94

1.3

0.57

2.40

nmol/l

1.13

395

2201

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

607

3733

1.65

28.94

1.5

1.4

15.67

28.72

u/l

33.09

504

3044

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

477

2758

1.75

28.61

1.1

125.62

117.87

5.48

433

2521

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

178

719

2.49

28.24

1.6

1.4

431.41

535.48

mu/l

1.08

173

694

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

180

734

2.47

27.98

1.6

1.4

74.13

73.19

0.44

175

709

(3007930) Methemoglobin/Hemoglobin.total in Blood

808

5360

1.53

27.89

6.5

5.1

0.83

0.89

4.78

776

5059

(3017732) Neutrophils [#/volume] in Blood

2610

21032

1.28

27.78

3.2

3.1

4.87

4.32

e9/l

2.32

2322

18648

(1761482) Bacteria [#/volume] in Urine by Culture

478

2790

1.73

27.74

4.5

3.8

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

224

1011

2.23

27.62

15.4

14.5

6598.98

817.92

nmol/l

0.49

215

984

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

383

2099

1.84

27.51

1.1

98.19

95.70

0.97

363

1975

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

487

2871

1.72

27.27

1.7

1.6

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

231

1063

2.19

27.17

21.5

19.3

1450.09

2301.61

nmol/l

0.46

223

1023

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

1040

7353

1.44

26.09

2.0

1.9

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

3047

25248

1.25

25.38

2.2

2.1

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

704

4630

1.54

25.29

1.3

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

3316

27755

1.24

25.17

2.3

2.2

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

264

1319

2.02

25.04

1.1

297.50

290.93

mg/l

0.72

234

1221

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

1367

18056

0.74

24.86

1.7

1.6

3.38

3.48

mmol/l

2.57

956

12039

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

402

2306

1.76

24.84

1.1

1.50

1.48

g/l

0.48

366

2128

(40757494) Bilirubin.total [Moles/volume] in Blood

160

668

2.41

23.71

2.2

2.3

24.51

29.01

umol/l

0.15

(3024980) IgG subclass 4 [Mass/volume] in Serum

483

2954

1.65

23.59

1.5

1.6

0.69

0.71

g/l

0.16

404

2308

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

570

3640

1.58

23.33

1.5

1.6

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

2111

16934

1.28

22.98

5.8

4.3

30.52

32.51

15.70

1678

11892

(3023420) DNA double strand Ab [Units/volume] in Serum

1071

7793

1.40

22.81

1.7

2.0

5.43

7.40

iu/ml

1.75

227

1909

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

300

1617

1.87

22.80

1.2

56.92

61.15

u/l

0.69

275

1417

(3027315) Oxygen [Partial pressure] in Blood

454

2759

1.66

22.75

4.8

3.4

8.76

8.81

kpa

0.23

442

2708

(40767503) Oxygen content in Capillary blood by calculation

446

2698

1.67

22.74

3.1

2.4

16.67

16.76

0.27

436

2651

(3037756) Immunofixation for Serum or Plasma

415

2463

1.70

22.74

1.3

1.8

—

(3012501) Base excess in Blood by calculation

451

2737

1.66

22.72

4.8

3.4

3.06

2.31

mmol/l

5.61

316

1793

(3013290) Carbon dioxide [Partial pressure] in Blood

451

2738

1.66

22.68

4.8

3.4

5.23

4.96

kpa

9.27

439

2688

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1913

23829

0.78

22.39

1.9

3.71

3.38

ratio

21.06

1457

17816

(3002079) Sodium [Moles/time] in 24 hour Urine

175

780

2.26

22.35

1.3

176.24

152.95

mmol/24h

2.93

175

780

(3040151) Glucose [Moles/volume] in Capillary blood

277

1468

1.90

22.19

11.6

8.9

8.28

7.07

mmol/l

1.50

225

1230

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

588

3831

1.55

22.07

1.5

1.6

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

271

1431

1.91

21.96

1.3

1.2

118.98

113.03

pmol/l

0.95

271

1431

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

2226

18071

1.26

21.89

2.3

2.0

—

(3000034) Microalbumin [Mass/volume] in Urine

225

1126

2.01

21.33

3.8

2.8

78.13

62.31

mg/l

0.32

166

799

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

192

3.60

21.29

14.1

9.5

5.62

5.25

mmol/l

0.50

192

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

188

881

2.15

21.24

1.5

23.14

23.49

u/ml

0.02

167

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

260

1371

1.91

21.17

1.2

1.1

—

(3006270) Folate [Moles/volume] in Blood

221

1102

2.02

21.16

1.2

1.1

402.98

384.27

nmol/l

0.66

178

996

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

398

2385

1.68

21.07

1.5

1.8

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

128

510

2.52

21.04

2.3

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

249

1298

1.93

20.99

1.3

1.5

283.49

941.47

pmol/l

0.54

144

(3023511) Choriogonadotropin [Units/volume] in Urine

748

5178

1.46

20.98

1.5

1.3

—

(3021440) Promyelocytes/Leukocytes in Blood

1681

13285

1.29

20.47

4.9

4.6

0.10

0.12

0.63

477

3310

(3027570) Oxalate [Moles/time] in 24 hour Urine

4.90

20.32

2.3

1.4

349.07

310.03

umol/24h

0.56

(3035320) C reactive protein [Mass/volume] in Body fluid

240

1251

1.93

20.26

3.5

2.5

20.63

27.79

mg/l

3.89

191

874

(3002179) Metamyelocytes/Leukocytes in Blood

1672

13237

1.29

20.08

4.3

4.4

0.58

0.72

2.04

528

3715

(3017181) Myelocytes/Leukocytes in Blood

1740

13857

1.28

19.94

4.9

4.5

0.97

0.93

0.27

536

3865

(3044242) Glucose [Moles/volume] in Arterial blood

147

647

2.28

19.41

2.3

1.9

9.12

7.77

mmol/l

3.20

147

647

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1840

14826

1.27

19.13

2.1

1.9

—

(40768443) Skin Pathology biopsy report

964

7121

1.37

18.72

1.2

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

152

689

2.22

18.72

1.2

1.1

2.82

3.55

iu/ml

0.83

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

900

6576

1.39

18.69

1.7

1.6

—

(3051611) Lipemic interference index of Serum or Plasma

250

1358

1.85

18.64

3.6

3.2

16.08

13.62

index

1.35

155

802

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

163

762

2.15

18.60

1.2

1.3

74.29

60.65

titre

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

186

915

2.04

18.56

1.2

1.3

17.64

23.84

u/l

1.53

166

760

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

189

936

2.03

18.52

1.2

1.3

77.43

89.97

u/l

1.60

174

794

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

422

2658

1.60

18.39

1.2

176.00

178.00

titre

—

(3003329) Lymphocytes/Leukocytes in Synovial fluid

233

1244

1.88

18.34

1.5

25.81

34.26

3.16

152

751

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

114

460

2.49

18.31

1.4

1.3

74.37

125.22

nmol/l

6.97

343

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1303

10118

1.31

18.06

1.1

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

699

4916

1.44

18.06

1.2

1.1

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

416

2624

1.60

18.03

1.2

177.81

351.85

titre

1.17

200

(4062490) Immunoglobulin typing, IgG

310

1814

1.72

17.99

1.5

1.4

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

869

6367

1.38

17.75

1.2

1.3

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

220

1169

1.89

17.60

1.4

1.8

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

220

1169

1.89

17.60

1.4

1.8

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

220

1169

1.89

17.60

1.4

1.8

—

(4268621) Lupus anticoagulant assay

358

2192

1.65

17.52

2.4

2.3

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

130

570

2.29

17.38

1.7

1.4

—

(3045424) Erythrocytes [Presence] in Urine

1005

7571

1.35

17.21

2.3

2.1

0.17

0.12

estimate

0.09

314

2639

(3025159) Blasts/Leukocytes in Blood

1676

13570

1.26

16.64

5.2

4.8

0.11

0.38

2.29

451

3238

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

296

2.78

16.50

1.3

1.2

296.40

321.03

pmol/l

0.24

231

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

161

788

2.05

16.35

1.2

1.3

1452.50

382.50

titre

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

306

1836

1.68

16.24

1.5

1.4

2.83

2.98

g/l

0.85

246

1326

(3027135) IgG subclass 1 [Mass/volume] in Serum

306

1838

1.68

16.17

1.5

1.4

6.59

6.74

g/l

0.31

241

1331

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

243

1374

1.78

15.96

1.1

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

305

1837

1.67

15.96

1.5

1.4

0.42

0.41

g/l

0.13

244

1325

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

117

511

2.30

15.83

1.1

1.2

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

293

2.74

15.69

1.3

1.4

29.06

25.42

g/l

1.05

219

(4198724) Urine methamphetamine measurement

166

837

1.99

15.56

2.2

2.6

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

341

2.59

15.45

1.6

1.3

13.98

13.01

g/l

0.45

248

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

315

1934

1.64

15.32

1.2

1.3

—

nmol/l

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

127

583

2.19

15.27

1.0

1.1

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

4.25

15.20

1.8

1.9

43.08

47.53

umol/l

0.49

(44806118) Parainfluenza type 4 nucleic acid detection

312

1915

1.64

15.19

1.6

1.5

—

(44790049) Parainfluenza type 3 nucleic acid detection

312

1915

1.64

15.19

1.6

1.5

—

(44790048) Parainfluenza type 2 nucleic acid detection

312

1916

1.64

15.16

1.6

1.5

—

(44790047) Parainfluenza type 1 nucleic acid detection

312

1917

1.64

15.13

1.6

1.5

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

203

1107

1.84

15.05

1.5

6.77

7.48

ug/l

0.48

185

1007

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

408

2.41

14.81

2.4

1.8

5417.02

14856.48

e6/l

0.83

187

(3004775) Volume in Urine collected for unspecified duration

165

846

1.96

14.77

2.5

2.3

713.04

639.37

1.00

113

618

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

122

560

2.19

14.69

2.0

2.5

0.69

1.25

ug/l

3.67

110

536

(3020491) Glucose [Moles/volume] in Blood

200

1098

1.83

14.53

2.0

1.7

7.20

6.26

mmol/l

3.32

132

819

(3015171) Extractable nuclear Ab [Units/volume] in Serum

977

7518

1.32

14.46

1.3

0.65

1.13

u/ml

0.98

582

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

176

932

1.90

14.33

1.2

—

(3014271) Vancomycin [Susceptibility]

100

427

2.35

14.30

3.2

2.8

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

275

1662

1.66

14.26

1.6

59.69

53.45

1.63

173

1035

(21494890) Protein electrophoresis panel - 24 hour Urine

217

1236

1.76

13.97

1.5

2.2

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

108

483

2.24

13.88

2.5

2.0

453.24

2546.92

e6/l

0.65

312

(3006922) Hepatitis E virus Ab [Presence] in Serum

242

1437

1.69

13.44

1.1

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

134

3.44

13.39

1.1

—

(3044927) Protein electrophoresis panel - Urine

197

1105

1.79

13.38

1.3

1.1

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

536

7449

0.71

13.28

1.4

1.5

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

494

3460

1.44

13.15

1.5

1.4

—

(3027035) Albumin [Mass/time] in 24 hour Urine

126

3.50

13.15

1.4

1.2

447.00

349.46

mg/24h

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

220

1283

1.72

13.07

1.4

85177.05

97923.68

e6/l

0.15

160

853

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

260

1587

1.65

13.02

2.6

1.9

25.18

23.87

mg/l

0.19

121

566

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

546

7537

0.72

12.99

1.4

1.5

1.16

ratio

0.01

285

4510

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

549

7566

0.72

12.93

1.4

1.5

1.17

1.19

ratio

0.14

289

4571

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

549

7565

0.72

12.92

1.4

1.5

0.97

0.95

ratio

0.35

288

4537

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

287

1800

1.60

12.89

1.6

1.5

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

634

4654

1.38

12.88

3.2

3.4

1.70

1.39

mg/l

14.25

585

4323

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

601

4375

1.39

12.85

1.3

4.62

3.36

u/ml

0.18

315

(3004809) Band form neutrophils/Leukocytes in Blood

343

2244

1.54

12.82

2.8

3.5

1.21

1.53

1.28

305

2041

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

1000

7850

1.29

12.77

1.5

1.3

194.78

230.04

miu/ml

2.58

448

3870

(3002619) Bacteria identified in Specimen by Culture

393

2.32

12.74

1.2

—

(3023410) Appearance of Cerebral spinal fluid

286

1800

1.60

12.66

1.4

1.5

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

413

2831

1.47

12.34

1.5

1.4

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

136

699

1.95

12.18

1.2

1.3

0.33

0.30

g/l

5.67

108

565

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

603

4432

1.37

12.17

1.3

11.65

18.63

u/ml

0.33

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

14528

140945

1.15

12.15

29.1

17.1

329.35

332.65

g/l

307.65

14450

140205

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

129

653

1.98

12.08

1.2

112.92

109.49

0.86

112

601

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

185

1052

1.77

12.05

2.0

100.63

98.81

0.30

176

968

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

180

1017

1.78

11.99

1.1

2.75

7.61

nmol/l

1.23

189

(3008898) HLA-B27 [Presence]

952

7489

1.29

11.97

1.1

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

524

3782

1.40

11.82

1.5

1.4

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

206

1215

1.70

11.80

3.2

4.0

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

273

1730

1.59

11.78

1.6

1.5

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

545

3967

1.39

11.70

1.2

1.3

3.81

3.67

mmol/l

2.78

515

3763

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

226

1373

1.65

11.59

1.5

1.9

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

207

1229

1.69

11.58

3.3

2.8

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

519

3754

1.39

11.57

1.4

17.56

22.42

u/ml

—

(3001556) Androgen free Index in Serum or Plasma

179

2.91

11.54

1.5

1.1

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

485

3484

1.40

11.27

1.5

1.4

153.37

151.03

au/ml

0.16

130

978

(3013166) Neutrophils/Leukocytes in Synovial fluid

365

2.28

11.20

1.3

57.07

49.86

0.93

316

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

110

541

2.04

11.19

3.1

2.8

0.61

mmol/l

0.18

110

541

(43055442) Apixaban [Mass/volume] in Serum or Plasma

156

3.02

11.13

1.4

1.5

97.00

116.70

ug/l

0.72

134

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

599

7947

0.75

11.05

1.1

0.67

0.61

ratio

1.33

876

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

601

7963

0.75

10.98

1.5

47.94

63.62

ug/l

20.42

477

6599

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

467

3350

1.40

10.95

1.6

1.5

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

240

1511

1.60

10.70

1.5

1.8

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

281

1840

1.54

10.55

1.5

—

(3028271) Lactate [Moles/volume] in Capillary blood

306

2041

1.51

10.54

2.2

1.7

1.76

1.68

mmol/l

0.85

296

1994

(3017315) Amylase [Enzymatic activity/volume] in Urine

147

815

1.81

10.50

1.5

1.2

264.12

328.83

u/l

0.42

139

751

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

199

1202

1.66

10.48

1.5

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

317

2137

1.49

10.38

1.4

—

(3032057) Clostridioides difficile [Presence] in Stool

248

2.50

10.35

2.0

1.9

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

223

1391

1.61

10.35

1.2

1.3

1.15

1.75

u/ml

0.66

135

789

(3005988) Vibrio sp identified in Specimen by Organism specific culture

281

1849

1.53

10.33

1.5

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

741

5757

1.30

10.29

1.3

24.52

34.08

u/ml

0.43

348

(3000093) Morphology [Interpretation] in Blood Narrative

210

1294

1.63

10.24

1.1

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

280

1848

1.52

10.16

1.5

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

359

2493

1.45

10.12

1.2

32.63

10.91

u/ml

—

119

(37021550) Renin [Units/volume] in Plasma --upright

281

2.39

10.11

1.3

84.14

62.41

mu/l

0.37

217

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

158

906

1.75

10.09

1.6

5.46

6.62

u/l

0.73

128

741

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

353

2455

1.45

9.88

1.2

1.4

21.75

13.16

u/ml

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

147

831

1.78

9.87

1.4

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

689

5339

1.30

9.78

1.3

7.47

7.77

u/ml

0.05

801

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

525

3915

1.35

9.75

1.3

1.4

39.98

28.08

e6/l

0.19

377

2904

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

532

3979

1.35

9.69

1.4

1073.38

2327.86

e6/l

0.58

399

3136

(3022621) pH of Urine by Test strip

1544

13095

1.20

9.66

2.9

2.4

5.99

6.11

5.75

998

8315

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

585

4447

1.33

9.55

1.3

33.95

40.83

u/ml

0.41

424

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

742

5825

1.29

9.54

1.5

2.69

5.80

iu/ml

0.32

134

1007

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

288

1942

1.49

9.47

1.5

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

108

562

1.93

9.45

1.4

1.5

13.41

14.62

pmol/l

1.27

475

(3024522) Salmonella sp identified in Specimen by Organism specific culture

288

1943

1.49

9.44

1.5

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

483

6453

0.74

9.39

1.5

1.6

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

161

948

1.70

9.39

1.7

1.8

150.16

138.01

1.26

154

893

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

292

1978

1.48

9.39

1.5

—

(3024263) Appearance of Synovial fluid

126

692

1.83

9.33

1.6

1.8

—

(3022806) Fractional oxyhemoglobin in Capillary blood

243

1586

1.54

9.32

2.1

1.7

89.41

90.52

2.20

237

1565

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

587

4482

1.32

9.30

1.3

468.10

497.65

mg/l

0.96

569

4308

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

686

5350

1.29

9.29

1.3

10.08

5.28

u/ml

0.48

528

(3004451) EKG impression Narrative

120

651

1.85

9.25

1.2

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

143

818

1.75

9.25

1.4

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

358

2530

1.42

9.22

1.4

1.3

7.38

6.87

mmol/l

3.06

321

2288

(3029075) Extractable nuclear Ab panel - Serum

191

1183

1.62

9.18

1.1

—

0.27

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

169

2.73

9.14

1.9

2.0

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

650

8307

0.77

9.13

1.1

1.48

1.55

g/l

9.81

650

8301

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

182

1117

1.64

9.08

1.2

1.1

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

325

2.19

8.80

1.4

1.5

0.36

0.33

mmol/l

0.09

(3023419) Bacteria identified in Sputum by Culture

252

1680

1.51

8.79

2.5

2.7

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

520

3936

1.33

8.78

1.2

58.64

46.52

u/ml

—

(3005033) Fetal Nuchal fold Thickness US

467

6206

0.75

8.77

1.4

1.5

1.28

1.26

0.39

308

4556

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

492

3695

1.34

8.76

1.2

1.3

265.76

260.63

u/ml

0.15

299

2432

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

275

2.30

8.75

1.1

1.0

0.36

0.09

u/ml

0.52

170

(3044007) Cell count panel - Peritoneal fluid

425

2.03

8.75

2.3

1.9

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

687

5403

1.28

8.74

2.0

2.1

26.23

10.82

iu/l

0.29

256

2376

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

371

2674

1.40

8.57

2.3

2.9

375.10

1720.31

u/ml

—

135

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

401

2937

1.37

8.41

1.4

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

479

6303

0.75

8.41

1.4

1.5

—

(3003181) Sodium [Moles/volume] in Urine

333

2372

1.41

8.25

1.2

1.4

62.94

mmol/l

0.00

256

1894

(3042517) Benzodiazepines panel - Urine

252

2.31

8.17

2.4

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

277

3955

0.70

8.17

1.3

—

(3020961) Endomysium IgA Ab [Titer] in Serum

1121

9390

1.21

8.04

1.1

113.33

192.26

titre

1.13

265

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

475

1.92

7.96

1.3

2.0

38.97

40.71

g/l

2.01

475

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

339

2.10

7.96

1.2

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

331

2379

1.40

7.82

1.3

40.91

58.74

u/ml

0.62

154

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

116

660

1.76

7.73

1.2

112.01

110.09

0.22

111

591

(4094501) Cardiovascular stress test using bicycle ergometer

559

4360

1.29

7.64

1.1

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

3.97

7.59

2.2

297.60

249.75

ug/l

0.42

(3016750) Collection duration of Urine

112

635

1.77

7.56

2.2

2.3

510.41

499.32

min

0.65

511

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

451

3424

1.33

7.52

4.7

6.1

13620.04

1382.60

iu/ml

0.46

499

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

243

1664

1.47

7.50

2.9

3.5

4.95

8.63

nmol/l

0.55

222

1611

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

162

1016

1.60

7.49

1.5

1.4

5.80

5.46

mmol/l

3.42

149

967

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

947

7873

1.21

7.37

1.5

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

565

4435

1.28

7.36

2.3

2.7

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

238

1630

1.47

7.35

1.2

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

148

2.64

7.35

1.0

1.2

39.27

43.40

mg/l

0.74

(40759836) Histone Ab [Presence] in Serum by Immunoblot

239

1643

1.46

7.25

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

237

1628

1.46

7.22

1.2

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

112

647

1.74

7.12

1.1

95.73

91.79

0.80

292

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

196

1300

1.51

7.10

1.2

1.4

12.90

11.45

umol/l

2.03

182

1233

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

105

596

1.77

7.09

1.4

1.5

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

105

596

1.77

7.09

1.4

1.5

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

3.25

7.08

1.0

0.40

0.09

u/ml

0.74

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

199

2.37

7.07

1.9

1.8

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

193

2.39

7.06

4.5

2.4

1.47

1.09

mmol/l

0.39

133

(3017354) Segmented neutrophils/Leukocytes in Blood

216

1467

1.48

6.99

2.7

3.5

59.45

56.35

1.43

189

1278

(3018333) Ribosomal P Ab [Presence] in Serum

223

1526

1.47

6.95

1.2

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

591

4702

1.27

6.92

1.1

1.35

2.00

u/ml

1.49

350

2425

(3003888) Timothy IgE Ab [Units/volume] in Serum

523

4099

1.28

6.92

1.1

3.24

5.11

u/ml

4.13

310

2141

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

218

1487

1.47

6.90

1.1

7.40

7.64

iu/ml

0.05

433

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

142

884

1.61

6.82

1.1

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

6.67

6.79

4.9

6.4

0.20

0.16

mmol/l

0.45

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

327

2.02

6.77

1.2

20.20

9.80

pmol/l

0.74

128

(3014148) Varicella zoster virus Ab [Titer] in Serum

379

2859

1.33

6.66

1.2

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

241

1688

1.43

6.66

1.2

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

205

2.30

6.64

8.5

7.8

65.66

70.04

0.41

156

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

227

1574

1.45

6.62

1.2

—

(3012565) Volume of 24 hour Urine

111

655

1.70

6.57

2.1

2.2

1933.27

2031.41

0.41

101

601

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

226

1570

1.44

6.54

1.2

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

3.25

6.53

1.4

1.6

515.12

551.93

nmol/l

0.12

(3051101) Glucose [Moles/volume] in Cord blood

176

2.39

6.49

5.8

5.2

8.05

8.26

mmol/l

0.23

176

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

227

2.21

6.44

1.5

1.8

435718.75

359169.05

nmol/l

0.08

191

(3006576) Bicarbonate [Moles/volume] in Blood

396

1.90

6.43

6.2

5.9

25.25

24.92

mmol/l

0.23

372

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

124

2.66

6.38

1.2

1.1

15.39

13.90

nmol/l

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

260

1865

1.40

6.31

1.2

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

107

635

1.69

6.23

1.1

1.2

98.16

93.03

0.71

293

(3022493) Free Hemoglobin [Mass/volume] in Plasma

107

636

1.69

6.20

7.6

4.6

1798.49

2448.39

mg/l

0.13

471

(3025018) Bordetella pertussis Ab [Titer] in Serum

204

1406

1.46

6.18

1.1

1.2

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

203

1403

1.45

6.07

1.7

1.5

1.05

1.26

promille

1.49

167

1107

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

366

2787

1.32

6.07

1.6

1.5

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

217

1521

1.43

6.02

1.9

1.8

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

287

2.02

6.02

1.1

1.4

0.20

0.33

nmol/l

1.51

197

(3036312) Salmon IgE Ab [Units/volume] in Serum

111

2.71

5.99

1.0

1.1

0.00

0.82

u/ml

1.30

(40771922) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by based on 1.73 sq M

112

2.68

5.90

1.4

1.3

1.17

1.95

ml/s/173m2

0.49

(3026389) Candida sp identified in Specimen by Organism specific culture

351

2670

1.32

5.88

1.5

1.3

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

494

3931

1.26

5.85

1.1

0.50

1.02

u/ml

3.71

240

1676

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

3.07

5.75

1.0

0.19

0.07

u/ml

0.43

(3034891) Synovial lining cells/cells in Synovial fluid

109

667

1.64

5.69

1.5

4.38

3.48

0.20

141

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

1454

12808

1.15

5.67

2.3

2.4

21.79

19.93

au/ml

0.34

137

1671

(4024509) Urine culture

811

6831

1.20

5.57

2.1

1.8

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

459

1.75

5.32

1.6

10.59

8.59

ug/l

3.01

459

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

518

4195

1.24

5.30

1.5

0.44

0.42

nmol/l

0.15

423

3243

(3012494) Peanut IgE Ab [Units/volume] in Serum

507

1.70

5.21

1.0

1.1

1.35

2.96

u/ml

0.46

292

(3034274) Bile acid [Moles/volume] in Serum --fasting

429

3408

1.26

5.20

2.4

2.2

5.80

6.33

umol/l

0.38

303

2479

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

103

637

1.62

5.19

1.3

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

103

637

1.62

5.19

1.3

1.5

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

176

2.22

5.17

1.1

1.54

2.00

iu/ml

0.77

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

700

8325

0.83

5.16

1.5

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

168

1159

1.45

5.15

1.1

1.06

ratio

0.31

142

967

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

1348

11896

1.14

5.14

1.2

1.3

37.65

50.47

au/ml

1.44

777

(3043410) Blood group antigens tested for on Red Blood Cells

376

1.81

5.14

1.8

1.7

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

1202

10533

1.15

5.07

2.5

3.2

38.63

47.56

u/ml

1.02

1155

10198

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

153

1041

1.47

5.04

1.4

1.3

454.86

394.63

u/l

0.45

144

993

(3028308) Erythrocytes [#/volume] in Pleural fluid

171

1189

1.44

5.04

1.7

1.4

53489.76

47774.48

e6/l

0.11

641

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

218

2.07

5.00

3.0

2.1

7.84

7.68

mmol/l

0.08

125

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

120

781

1.54

4.90

1.1

97.64

94.31

0.53

636

(3023199) Leukocytes [#/volume] in Pleural fluid

189

1347

1.41

4.87

1.7

1.5

4196.55

3347.43

e6/l

0.15

130

917

(3016330) Potassium [Moles/time] in 24 hour Urine

221

2.04

4.84

1.2

1.3

—

87.33

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

163

2.21

4.76

1.1

0.11

0.03

u/ml

0.57

163

(40761536) Microorganisms panel - Urine sediment

1477

13181

1.13

4.75

4.4

3.6

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

600

4994

1.21

4.74

1.2

3.85

4.10

0.31

857

(37208534) Antinuclear antibody arbitrary concentration in serum

607

1.60

4.70

1.2

1.1

—

(3004437) Lymphocytes/Leukocytes in Peritoneal fluid

108

2.50

4.69

3.2

1.6

66.89

60.57

0.39

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

144

984

1.47

4.68

2.6

1.7

—

(1761868) Lipid panel - Serum or Plasma

6880

71744

0.93

4.65

3.4

2.8

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

188

1351

1.40

4.64

2.3

3.8

—

(40768800) Prostate Pathology biopsy report

145

2082

0.69

4.62

1.2

—

(4281824) Cell count and differential, peritoneal fluid

247

1857

1.33

4.59

1.1

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

121

803

1.51

4.55

1.4

1.6

—

(3026470) Cobalt [Mass/volume] in Blood

613

1.59

4.53

2.1

2.3

4.70

3.48

ug/l

0.70

568

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

149

1032

1.45

4.53

1.5

1.4

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

181

2.10

4.45

2.7

2.9

45.20

65.75

pmol/l

1.15

155

(3025577) Chromium [Mass/volume] in Blood

594

1.59

4.41

2.1

2.3

2.32

2.46

ug/l

0.14

502

(3008295) Osmolality of Serum or Plasma

208

1539

1.36

4.32

1.4

1.5

283.48

279.62

mosm/kgh2o

1.51

141

1195

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

303

1.82

4.27

1.2

—

(3034426) Prothrombin time (PT)

592

1.57

4.24

1.3

1.2

27.40

28.10

0.48

592

(3018133) Calcium [Moles/volume] in Urine

297

1.82

4.22

1.6

1.8

2.79

2.71

mmol/l

0.10

273

(3047181) Lactate [Moles/volume] in Blood

503

4169

1.21

4.20

8.0

5.2

1.38

1.26

mmol/l

2.22

457

3692

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

148

1040

1.43

4.19

2.0

1.9

2.20

1.83

u/field

0.39

581

(3036670) Protein [Mass/volume] in Synovial fluid

364

1.73

4.18

1.3

1.2

36.50

39.76

g/l

0.94

182

(40768446) Kidney Pathology biopsy report

626

1.55

4.18

1.6

1.7

—

(3041096) Erythrocytes [Presence] in Urine by Automated

5189

49371

1.07

4.15

3.8

3.0

0.34

0.11

estimate

0.52

1610

14435

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

146

1028

1.42

4.10

1.5

1.4

7.01

5.66

u/l

0.64

125

892

(3047189) Immunofixation for 24 hour Urine

559

1.58

4.07

1.4

1.9

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

602

5091

1.19

4.06

2.9

3.8

615.10

1718.09

u/ml

1.10

511

4406

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

119

811

1.47

3.98

1.4

1.3

13.05

15.28

u/l

0.45

110

748

(3038177) Helicobacter pylori Ab [Presence] in Serum

396

3225

1.23

3.96

1.2

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

2.47

3.95

1.1

1.3

146.00

105.17

ug/l

0.66

(3033923) Metanephrine [Moles/time] in 24 hour Urine

275

1.82

3.93

1.1

0.78

0.89

umol/24h

0.19

145

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

118

806

1.47

3.91

1.1

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

144

2.15

3.91

1.2

1.1

0.31

0.78

iu/ml

2.35

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

125

864

1.45

3.90

1.1

18.23

21.78

u/l

0.62

116

785

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

107

719

1.49

3.85

1.4

2.0

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

107

719

1.49

3.85

1.4

2.0

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

107

719

1.49

3.85

1.4

2.0

—

(3003434) Protein [Mass/volume] in Pleural fluid

204

1536

1.33

3.83

1.6

1.4

34.43

33.69

g/l

0.38

184

1399

(3016038) Potassium [Moles/volume] in Urine

125

868

1.44

3.82

1.1

1.2

33.72

34.61

mmol/l

0.16

108

773

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

182

1348

1.35

3.81

1.2

83.89

80.09

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

233

1789

1.31

3.81

1.2

82.17

43.45

u/ml

—

101

(3045788) Cell count panel - Pleural fluid

154

1114

1.39

3.74

1.6

1.5

—

(1617658) Protocol used for examination of sentinel lymph nodes

1337

0.66

3.68

1.0

1.1

—

(3006462) Nitrate [Presence] in Urine

102

686

1.49

3.68

3.2

2.9

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

107

727

1.47

3.67

1.7

1.6

2.00

2.50

u/field

0.37

527

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

176

1307

1.35

3.65

1.3

1.2

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

106

721

1.47

3.62

1.4

2.0

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

528

1.56

3.62

1.4

2.3

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

381

1.66

3.59

1.1

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

124

871

1.43

3.59

1.1

80.67

81.03

u/l

0.02

117

789

(40760866) Procollagen type III.N-terminal propeptide [Units/volume] in Serum

7.78

3.55

1.0

1.1

1.11

0.91

u/ml

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

173

1291

1.34

3.49

1.3

1.2

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

550

1.53

3.46

3.2

1.73

1.29

0.98

550

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

519

1.54

3.44

1.4

2.3

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

519

1.54

3.44

1.4

2.3

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

386

1.63

3.44

1.1

1.15

1.44

u/ml

0.10

328

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

237

1.82

3.41

1.4

1.3

—

(3010375) cycloSPORINE [Mass/volume] in Blood

100

682

1.47

3.40

30.0

28.7

121.58

115.57

ug/l

0.30

551

(3000012) Reticulocyte production index

224

1741

1.29

3.39

2.1

2.0

1.07

0.90

2.57

162

1131

(3005011) Chlamydia sp Ab [Titer] in Serum

245

1.80

3.38

1.6

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

427

1.59

3.37

5.5

3.0

5.26

4.75

kpa

2.23

427

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

428

1.59

3.34

5.5

3.0

9.42

10.72

kpa

4.31

428

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

833

0.60

3.32

1.0

1.1

—

(4211845) Urine protein measurement

108

752

1.44

3.31

3.1

2.8

—

(46234826) Other cells/Leukocytes in Peritoneal fluid by Manual count

2.41

3.29

3.3

1.6

17.82

20.11

0.14

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

232

2930

0.79

3.21

3.3

3.8

21.92

34.25

u/ml

2.42

225

2830

(3042733) HLA Ab [Presence] in Serum

546

1.50

3.16

5.2

5.1

—

(40762887) Creatinine [Moles/volume] in Blood

2.31

3.16

1.5

1.4

—

(44813793) Dust mix specific IgE antibody measurement

177

1348

1.32

3.15

1.1

—

(3041806) Other cells [#/volume] in Blood by Manual count

833

0.61

3.15

1.7

1.5

0.55

0.51

e9/l

0.47

833

(3019832) Treponema pallidum Ab [Presence] in Serum

2687

25212

1.08

3.12

1.9

1.8

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

107

754

1.42

3.10

1.2

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

3.17

3.05

1.5

1.1

42.83

29.37

mg/24h

0.86

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

377

1.59

3.00

1.5

1.6

0.41

0.39

ug/l

0.19

277

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

203

1586

1.28

3.00

1.4

1.5

—

(3026926) Nortriptyline [Moles/volume] in Serum or Plasma

2.75

2.98

1.6

1.5

437.60

217.97

nmol/l

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

140

1041

1.35

2.96

1.2

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

115

829

1.39

2.94

1.5

1.4

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

242

1937

1.25

2.94

1.0

1.1

—

62.51

—

(40768806) Pleura Pathology biopsy report

156

1180

1.32

2.94

1.6

1.5

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

212

1671

1.27

2.93

2.0

2.1

31.12

32.69

4.95

212

1661

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

542

1.48

2.87

2.5

3.0

28.93

28.18

umol/l

0.19

415

(21491868) Cryoglobulin [Mass/volume] in Serum

626

1.44

2.83

1.1

1.2

—

0.23

g/l

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

215

1.77

2.82

1.1

—

(3017704) Immunofixation for Urine

620

1.44

2.78

1.2

1.8

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

596

1.44

2.76

1.2

1.3

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

533

4622

1.16

2.76

1.4

130.24

118.85

pmol/l

0.16

513

4514

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

680

1.41

2.75

2.3

2.0

6.61

9.66

mg/l

7.51

564

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

6.00

2.69

1.0

0.49

0.07

u/ml

—

(4027681) Cerebrospinal fluid IgG ratio and IgG index

167

1296

1.29

2.65

1.2

1.3

0.68

ratio

0.02

104

741

(3000060) B lymphocytes [#/volume] in Blood

552

1.45

2.65

1.7

2.3

0.14

0.21

e9/l

0.69

252

(3046904) Somatotropin [Units/volume] in Serum or Plasma

3.14

2.64

2.4

2.2

1.88

2.30

mu/l

0.20

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

325

2718

1.20

2.63

1.1

2.42

2.84

0.44

558

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

712

1.39

2.61

1.1

—

0.65

—

(3000285) Sodium [Moles/volume] in Blood

222

1.71

2.56

1.4

1.2

138.13

138.63

mmol/l

0.26

178

(3001019) Free T4 and TSH panel - Serum or Plasma

1263

11586

1.10

2.56

1.7

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

574

1.43

2.53

2.0

2.1

64.83

62.53

ug/l

0.13

561

(3036782) Glucose [Moles/volume] in Pleural fluid

156

1209

1.29

2.52

1.4

1.3

6.59

6.24

mmol/l

0.77

142

1129

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

411

1.51

2.51

1.0

1.2

72.63

71.11

—

109

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

2556

27049

0.94

2.50

3.9

4.1

22.08

21.81

0.30

922

12470

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

348

1.55

2.49

1.2

1.3

39.24

41.41

0.14

241

(3039000) Anion gap in Blood by calculation

330

2780

1.19

2.48

10.0

6.4

11.66

11.25

mmol/l

1.32

303

2497

(3036180) Methadone [Presence] in Urine

2.97

2.48

1.1

2.6

—

(3018572) Chloride [Moles/volume] in Blood

330

2781

1.19

2.47

10.0

6.4

105.11

105.29

mmol/l

0.35

303

2499

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

413

1.50

2.47

1.1

1.2

98.20

84.41

—

116

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

307

2575

1.20

2.43

1.1

1.2

1.09

1.06

—

135

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

226

1.68

2.42

1.0

0.01

0.20

u/ml

2.04

131

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

2.29

2.40

1.3

1.5

0.00

0.09

u/l

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

454

3937

1.16

2.40

1.1

1.42

1.74

u/ml

0.43

266

1929

(3019768) Coxiella burnetii Ab [Presence] in Serum

105

2.00

2.30

1.2

—

(40762814) Titanium [Mass/volume] in Blood

155

1.81

2.28

2.1

2.6

2.70

3.86

ug/l

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

345

2942

1.18

2.28

4.9

3.1

23.86

25.80

mg/l

0.52

240

1976

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

216

1.67

2.24

1.1

—

(3017509) Phencyclidine [Presence] in Urine

224

1.65

2.23

1.6

—

(3026657) Rickettsia conorii Ab [Titer] in Serum

3.10

2.22

1.0

1.1

—

371.20

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

152

1918

0.79

2.22

1.7

1.6

8.80

7.51

mmol/l

8.56

142

1854

(3029612) Listeria sp Ab [Titer] in Serum

2.68

2.20

1.2

1.5

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

166

1.75

2.14

1.3

1.1

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

207

1698

1.22

2.12

1.1

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

389

1.47

2.07

1.1

—

(3001729) Color of Synovial fluid

2.02

2.05

1.1

1.5

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

190

1552

1.23

2.04

1.1

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1477

13785

1.08

2.04

1.6

600.14

1058.37

mu/l

88.82

1208

11610

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

204

1680

1.22

2.02

1.1

1.2

43.00

39.30

mg/l

0.63

182

1421

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

351

1.48

2.00

1.3

1.1

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

152

1217

1.25

1.97

1.8

2.2

—

(4015189) Microbial culture of sputum

306

1.50

1.91

3.0

2.1

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

356

1.46

1.89

1.5

1.8

51.92

29.99

u/l

0.33

323

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

105

808

1.30

1.88

1.5

1.4

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

220

1.59

1.87

1.3

5.90

5.65

mmol/l

0.87

220

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

111

862

1.29

1.86

1.2

1.1

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

197

1633

1.21

1.86

1.1

231.39

244.73

mg/l

0.61

181

1445

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

714

1.32

1.85

2.8

2.5

53.58

50.72

umol/l

0.33

640

(3024932) HLA-DR beta [Type]

491

1.39

1.85

1.1

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

391

3429

1.14

1.85

1.1

17.73

14.22

au/ml

0.46

1003

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

100

1.90

1.85

1.1

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1533

14388

1.07

1.84

3.3

4.3

33.04

22.16

ug/l

0.64

1198

11287

(3038026) Centromere Ab [Units/volume] in Serum

158

1283

1.23

1.83

1.2

42.74

51.29

u/ml

0.22

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

269

1.53

1.83

4.4

6.6

—

3154.35

—

(3024471) HLA-A [Type]

502

1.38

1.81

1.0

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

102

787

1.30

1.81

1.1

4.49

10.17

u/ml

2.48

131

(3001686) Cold agglutinin [Titer] in Serum or Plasma

278

1.51

1.80

1.1

1.2

26.80

97.48

titre

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

2.57

1.80

1.0

1.2

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

2.76

1.79

1.0

0.06

0.44

u/ml

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

764

1.30

1.76

1.5

1.4

—

(40765089) Chromosome analysis panel - Blood by G-banded

689

0.70

1.76

1.0

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

102

1.86

1.75

1.2

1.1

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

260

2226

1.17

1.73

1.2

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

125

1.76

1.71

1.0

0.13

u/ml

0.00

125

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

332

1.45

1.68

7.1

5.82

5.95

kpa

0.60

308

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

172

1.63

1.66

1.1

1.2

—

(3016031) Almond IgE Ab [Units/volume] in Serum

149

1.68

1.66

1.0

0.14

0.41

u/ml

0.97

(3009871) Measles virus Ab [Titer] in Serum

103

808

1.28

1.64

1.7

1.6

4300.00

3193.58

titre

—

134

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

907

0.75

1.61

1.6

1.9

—

(3001218) Citrate [Mass/time] in 24 hour Urine

2.50

1.59

1.4

1.5

432.00

402.81

mg/24h

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

2.33

1.58

1.0

1.2

—

(36303858) Crystals [Presence] in Urine

3.00

1.58

1.2

—

(3027874) Urate [Moles/volume] in Urine

2.27

1.55

1.1

1.38

1.47

mmol/l

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

264

1.48

1.55

1.6

2.0

49.07

48.76

pmol/l

0.01

227

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

167

1392

1.20

1.55

1.2

1.4

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

1114

0.78

1.54

1.2

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

289

1.45

1.54

2.4

2.6

454.79

131.42

ug/l

0.31

289

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

240

1.50

1.53

1.1

1.4

83.62

77.44

ng/l

0.06

146

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

2.03

1.53

1.1

278.46

249.83

nmol/l

0.17

(3016273) Islet cell 512 Ab [Units/volume] in Serum

108

1.76

1.50

1.0

—

(3029396) Erythrocyte agglutination [Presence] in Blood

780

0.74

1.48

2.8

3.1

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

452

0.66

1.46

1.2

46.80

73.16

ug/l

4.96

452

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

505

1.33

1.46

2.0

1.6

167.77

141.58

au/ml

0.17

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

155

1.61

1.46

1.5

1.6

0.81

2.05

mg/l

1.49

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

155

1.61

1.46

1.5

1.6

2.22

1.85

mg/l

0.10

111

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

155

1.61

1.46

1.5

1.6

2.37

2.33

mg/l

0.01

101

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

155

1.61

1.46

1.5

1.6

1.17

2.33

mg/l

1.26

103

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

155

1.61

1.46

1.5

1.6

1.00

1.17

mg/l

0.12

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

155

1.61

1.46

1.5

1.6

2.05

1.49

mg/l

0.46

112

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

155

1.61

1.46

1.5

1.6

0.75

2.66

mg/l

3.45

105

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

155

1.61

1.46

1.5

1.6

2.43

4.61

mg/l

1.97

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

155

1.61

1.46

1.5

1.6

0.44

0.93

mg/l

1.07

105

(3017958) Strawberry IgE Ab [Units/volume] in Serum

1.97

1.43

1.0

0.01

0.07

u/ml

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

336

1.40

1.42

1.1

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

138

1141

1.21

1.42

1.1

1.14

1.11

u/l

0.10

438

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

1.85

1.39

1.0

1.1

0.01

1.09

u/ml

1.27

(3004616) Nuclear Ab [Presence] in Serum

259

2262

1.15

1.39

1.4

1.3

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

328

2910

1.13

1.38

1.2

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

567

5183

1.10

1.38

1.1

4.27

5.55

eliau/ml

0.41

781

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

313

1.41

1.38

1.0

1.3

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

2.94

1.36

1.0

1.2

1.80

1.71

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

759

1.25

1.35

1.1

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

138

1148

1.20

1.35

2.2

2.7

569.20

514.69

e6/l

0.74

105

922

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

159

1.57

1.34

1.5

1.6

0.76

2.18

mg/l

2.11

104

(3017937) Magnesium [Moles/time] in 24 hour Urine

2.13

1.33

1.0

1.2

—

(3028433) Virus identified in Specimen by Culture

487

1.32

1.33

1.3

1.2

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

105

1.71

1.32

1.1

9.83

10.37

u/l

0.04

105

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

401

1.35

1.32

1.0

1.1

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

291

1.41

1.31

1.1

1.2

42.97

130.94

mg/l

0.86

211

(3011841) English Walnut IgE Ab [Units/volume] in Serum

193

1.50

1.28

1.0

0.01

1.62

u/ml

1.05

137

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

109

891

1.22

1.28

1.1

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

1.88

1.28

1.2

1.3

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

1.72

1.26

1.7

1.2

21.83

21.21

mmol/l

—

(3036071) Salmonella sp Ab [Titer] in Serum

597

1.27

1.26

1.1

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

660

1.26

1.25

2.2

2.6

156.10

150.98

nmol/l

0.19

588

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

303

1.39

1.24

1.4

1.2

18.28

177.79

ug/l

2.90

157

(3011436) Histone Ab [Units/volume] in Serum

363

1.35

1.24

1.0

1.1

—

25.38

—

(40760849) Centromere Ab [Presence] in Serum by Immunoblot

1.86

1.23

1.0

1.1

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

130

1087

1.20

1.23

1.1

1652.17

1508.67

miu/ml

0.68

130

1087

(3009015) Lactate [Moles/volume] in Synovial fluid

131

1.60

1.23

1.3

1.2

4.67

5.77

mmol/l

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

355

1.35

1.22

4.0

2.4

—

(40758292) HTLV I+II Ab panel - Serum

326

0.64

1.22

1.1

1.3

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

636

1.26

1.22

2.1

2.8

190.95

134.92

au/ml

0.51

105

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

334

2995

1.12

1.22

1.1

0.24

0.34

u/ml

0.45

132

889

(40758047) Lysozyme [Mass/volume] in Pleural fluid

108

1.67

1.21

1.2

1.1

12.99

10.85

mg/l

0.33

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

2.04

1.21

1.0

1.04

1.40

u/ml

—

(3018562) Neutrophils/Leukocytes in Cerebral spinal fluid

101

1.68

1.19

1.5

1.4

23.36

36.26

0.58

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

1.83

1.19

1.0

0.05

0.04

u/ml

0.18

(1175426) CD3 cells/Lymphocytes in Blood

151

1285

1.18

1.7

2.2

74.97

73.79

0.51

145

1235

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

189

1.48

1.18

1.0

1.1

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

720

1.24

1.17

2.7

3.5

7.85

8.74

mg/l

0.57

578

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

173

1.50

1.17

1.7

1.6

—

(3050794) Legionella sp Ab [Presence] in Serum

133

1.58

1.17

1.2

1.1

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

463

1.30

1.16

1.4

1.5

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

265

2352

1.13

1.16

2.4

2.5

24.99

25.40

iu/ml

0.02

196

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

455

1.30

1.15

1.1

25.93

30.23

iu/ml

0.27

455

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

1.81

1.14

5.2

10.0

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

142

1.55

1.13

1.5

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

368

3339

1.10

1.1

3.10

4.38

u/ml

1.12

178

1479

(3004982) Buprenorphine [Mass/volume] in Serum or Plasma

2.38

1.09

3.6

4.0

3.00

2.49

ug/l

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.82

1.08

1.2

1.1

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

152

1.51

1.08

2.0

2.3

0.52

0.74

u/field

0.75

152

(3013466) aPTT in Blood by Coagulation assay

120

1.58

1.08

1.2

1.1

35.26

36.68

0.84

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

2.19

1.08

1.0

1.1

1.54

1.64

mg/l

—

(3035880) pH of Pleural fluid

576

1.25

1.07

1.2

1.3

7.36

7.40

0.83

392

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

993

0.81

1.07

1.2

12.64

9.67

mm/h

1.55

993

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

202

1.44

1.07

1.0

0.81

9.51

u/ml

0.48

(3026250) Tacrolimus [Mass/volume] in Blood

775

1.21

1.06

41.2

41.7

7.21

7.34

ug/l

0.26

707

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

128

1087

1.18

1.06

1.2

1.3

—

(3026726) Creatinine [Moles/volume] in Specimen

121

1.57

1.05

2.8

2.4

238.89

409.96

umol/l

0.58

114

(3004446) Plasmodium sp identified in Blood by Light microscopy

203

1.43

1.04

2.6

2.5

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

220

1.41

1.04

1.0

0.19

2.11

u/ml

0.47

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

113

952

1.19

1.03

1.2

1.3

1029.03

1040.70

titre

0.04

199

(40757373) Influenza virus identified in Isolate

255

1.37

1.02

1.7

1.6

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

307

1.34

1.01

7.0

7.2

6.50

5.58

kpa

1.13

307

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

428

3938

1.09

0.98

1.4

1.3

3.48

3.40

ug/l

0.08

392

3551

(3011412) CD3 cells [#/volume] in Blood

181

1589

1.14

0.98

2.1

2.5

1455.68

1230.51

e6/l

2.68

151

1383

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

189

1.43

0.98

1.1

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

1.80

0.98

1.1

1.3

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

201

1778

1.13

0.98

3.8

5.2

65.45

95.56

u/ml

0.56

628

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

106

894

1.19

0.97

1.2

—

(4212803) Bone marrow aspirate examination

108

1.57

0.96

1.1

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

156

1359

1.15

0.95

1.0

0.56

1.92

u/ml

1.68

287

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

170

1935

0.88

0.95

1.5

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

0.00

0.95

0.0

5.2

—

(3033086) Enterovirus Ab [Titer] in Serum

1.76

0.94

1.0

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

123

1054

1.17

0.94

1.8

1.5

76.13

77.66

umol/l

0.16

123

1054

(3031659) Enterovirus Ab [Titer] in Cerebral spinal fluid

1.89

0.94

1.0

1.1

—

(36304315) Certolizumab Ab [Units/volume] in Serum or Plasma by Immunoassay

2.14

0.91

1.0

1.2

—

739.83

au/ml

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

151

1.46

0.90

2.3

3.1

1.78

1.24

mg/l

0.40

102

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

600

1.22

0.89

1.1

1.2

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

2.07

0.89

2.3

2.1

32.68

28.87

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

101

0.49

0.89

1.0

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

185

1.41

0.89

1.1

—

(21494434) Karyotype in Bone marrow

133

1155

1.15

0.87

1.1

1.2

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

195

1.39

0.85

1.0

0.11

0.47

u/ml

0.93

145

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

138

1207

1.14

0.83

2.3

2.8

244.29

234.04

e6/l

0.21

112

1019

(3014133) Dog dander IgE Ab [Units/volume] in Serum

382

3531

1.08

0.83

1.1

5.09

3.91

u/ml

0.38

201

1719

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1965

20290

0.96

0.81

2.8

3.0

0.63

0.74

ug/l

2.94

1252

12466

(3012920) Ethanol [Mass/volume] in Serum or Plasma

1.88

0.81

2.0

1.4

2.02

2.17

g/l

—

(3006598) pH of Arterial cord blood

1.70

0.80

1.4

1.1

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

0.00

0.79

0.0

1.0

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

139

1.44

0.79

1.4

1.2

0.06

0.49

u/ml

—

(3007542) Rye IgE Ab [Units/volume] in Serum

131

1.45

0.78

1.0

1.1

0.77

17.90

u/ml

—

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

101

869

1.16

0.77

1.6

2.0

196.80

196.69

u/l

0.01

101

860

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

122

1065

1.15

0.77

1.9

1.6

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

140

1.43

0.76

1.1

20.67

23.96

u/l

0.38

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

217

1.34

0.76

1.0

0.09

0.13

u/ml

0.12

100

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

348

0.75

1.0

6.52

8.42

u/ml

0.35

348

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

1.64

0.75

1.0

1.1

0.67

1.14

u/field

—

(3007733) Chloride [Moles/volume] in Urine

1.84

0.73

1.0

1.9

89.29

83.64

mmol/l

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

1.84

0.73

1.0

1.2

—

mmol/l

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

108

1.48

0.73

1.4

1.5

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

478

1.21

0.73

1.5

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

1.67

0.72

1.1

1.0

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

317

1.26

0.71

1.4

1.6

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

371

1.24

0.71

1.1

0.57

2.13

u/ml

0.87

239

(3020874) Milk IgE Ab [Units/volume] in Serum

155

1385

1.12

0.71

1.0

1.1

0.75

1.63

u/ml

1.38

393

(3007461) Platelets [#/volume] in Blood

17639

176001

1.05

0.69

35.1

20.8

266.74

258.09

e9/l

59.99

17439

173161

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

1.85

0.68

1.0

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

722

1.16

0.68

1.2

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

161

1.37

0.68

1.2

1.4

—

(3020618) Glucose [Moles/volume] in Synovial fluid

1.63

0.66

1.0

7.41

4.68

mmol/l

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

0.54

0.66

1.0

—

(3014891) Appearance of Pleural fluid

119

1.43

0.66

1.8

1.7

—

(44806071) Cardiolipin IgM antibody measurement

258

1.28

0.66

1.2

1.1

—

(3006567) Chloride [Moles/time] in 24 hour Urine

1.79

0.66

1.0

1.1

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

235

2156

1.09

0.66

1.6

1.7

—

(40768795) Lymph node Pathology biopsy report

141

1574

0.89

0.65

1.2

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

1.57

0.65

2.8

2.3

0.75

0.63

ug/l

0.56

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

1.61

0.65

10.5

9.0

107.40

104.63

g/l

—

(3042631) Mycobacterium sp identified in Specimen

182

1652

1.10

0.64

2.3

2.8

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

163

1.35

0.64

1.0

1.1

87.27

91.48

titre

0.11

163

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

181

1.33

0.62

1.0

1.1

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

720

1.15

0.61

1.1

1.0

4.58

10.49

u/ml

4.45

481

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

208

1.30

0.61

1.3

1.7

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

433

0.81

0.59

3.5

3.0

82.47

101.72

ng/l

0.48

223

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

1.54

0.59

1.3

1.1

33.23

30.00

umol/24h

—

(3020393) Adenovirus Ag [Presence] in Stool

131

1.37

0.59

1.1

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

363

1.21

0.58

1.1

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

155

1405

1.10

0.58

1.2

1.3

1.96

1.99

mmol/l

0.12

146

1324

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

228

1.27

0.58

1.1

1.2

—

(3007919) Fasciola sp Ab [Titer] in Serum

1.71

0.57

1.0

—

(3041672) Baker's yeast Ab [Presence] in Serum

106

1.42

0.57

1.0

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

1.48

0.57

1.0

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

274

1.24

0.56

1.0

1.1

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

0.56

0.55

1.0

2.0

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

203

1.28

0.55

1.0

1.1

—

(3052592) Norovirus Ag [Presence] in Stool

230

1.26

0.55

1.3

1.2

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

3422

33630

1.02

0.54

4.6

5.1

1.61

2.58

ug/l

9.01

3064

30796

(3015076) Soybean IgE Ab [Units/volume] in Serum

142

1289

1.10

0.53

1.0

0.18

0.75

u/ml

1.23

265

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

301

2820

1.07

0.53

2.6

3.7

605.28

640.25

u/ml

0.04

275

2562

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

125

1.36

0.53

1.1

47.64

27.49

u/ml

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

177

1625

1.09

0.53

1.6

1.4

22.87

35.61

nmol/l

9.23

155

1500

(3024731) MCV [Entitic mean volume] in Red Blood Cells

17639

176071

1.04

0.52

34.9

20.7

90.06

90.77

78.06

17546

174727

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

396

1.19

0.52

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

396

1.19

0.52

1.1

—

(3025130) Human papilloma virus identified in Specimen

431

4089

1.06

0.51

1.7

1.9

—

(3035941) MCH [Entitic mass]

17638

176067

1.04

0.51

34.9

20.7

29.71

30.26

286.24

17545

174726

(3022670) pH of Venous cord blood

1.46

0.50

1.2

1.1

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

162

1.30

0.49

1.1

1.3

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

127

1.34

0.49

1.0

1.1

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

284

2666

1.07

0.49

2.1

2.0

3.29

7.51

titre

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

110

992

1.11

0.48

1.7

1.90

2.18

u/ml

0.12

253

(3026361) Erythrocytes [#/volume] in Blood

17639

176090

1.04

0.48

35.0

20.7

4.56

4.50

e12/l

59.55

17402

172844

(3008536) Aspergillus sp Ab [Presence] in Serum

300

0.80

0.47

1.2

2.3

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

1.46

0.46

1.7

2.7

—

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

17637

176083

1.04

0.45

36.0

21.1

41.06

40.90

0.19

17542

174662

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

1.43

0.45

3.0

6.4

—

(3000963) Hemoglobin [Mass/volume] in Blood

17641

176127

1.04

0.44

35.3

20.9

134.33

135.34

g/l

18.17

17552

174804

(3010813) Leukocytes [#/volume] in Blood

17640

176124

1.04

0.43

35.1

20.8

7.39

6.61

e9/l

307.65

17399

172848

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

396

1.16

0.42

1.1

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

149

1.28

0.41

1.1

2.30

1.67

umol/24h

0.96

149

(3032868) Hemoglobin electrophoresis panel in Blood

167

1.26

0.41

1.7

1.5

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

249

1.21

0.41

2.9

3.0

84.91

22.36

mg/l

1.31

(3035153) Lemon IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.1

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

0.41

0.0

1.1

—

(3012138) Guinea pig epithelium IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

2.81

—

(3003740) Influenza virus B Ag [Presence] in Specimen

433

4143

1.05

0.41

1.1

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

548

1.13

0.40

1.1

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.40

0.0

3.0

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

0.40

0.0

1.1

—

1512.94

—

(3024316) Viscosity of Plasma

1.39

0.40

1.1

1.7

1.36

1.58

mpas

—

(3002523) Influenza virus A Ag [Presence] in Specimen

433

4146

1.05

0.40

1.1

—

(4035726) Immunohistochemistry procedure

1303

13343

0.97

0.39

1.4

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

371

1.16

0.39

1.1

—

(3016184) Myelin associated glycoprotein Ab [Units/volume] in Serum

1.38

0.38

1.1

1.3

—

9497.50

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

215

1.21

0.38

2.3

1.6

—

(3042951) Complement C1q Ab [Units/volume] in Serum

1.35

0.37

1.2

1.1

—

21.25

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

1.35

0.37

1.0

1.1

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

1.27

0.36

1.6

1.2

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

179

0.78

0.35

1.1

0.90

1.29

mom

1.95

179

(3013637) Mi-2 Ab [Presence] in Serum

459

0.87

0.35

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

459

0.87

0.35

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

459

0.87

0.35

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

459

0.87

0.35

1.1

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

310

1.16

0.35

1.8

1.4

1.20

1.17

mmol/l

1.30

310

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

107

986

1.09

0.35

1.3

124.32

173.10

pmol/l

2.92

107

986

(3020951) Lymphocytes/Leukocytes in Cerebral spinal fluid

190

1.21

0.34

1.4

1.3

62.75

57.33

0.23

(3045683) HLA typing for celiac disease panel - Blood or Tissue

135

1257

1.07

0.34

1.0

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

118

1.27

0.33

1.4

1.3

—

(46235168) Fasting glucose [Moles/volume] in Blood

199

0.80

0.33

1.7

1.2

7.62

7.01

mmol/l

—

(3013762) Body weight Measured

1.30

0.33

1.0

1.2

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

163

1531

1.07

0.33

1.9

2.1

23.68

26.15

ug/l

0.32

158

1508

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

0.68

0.33

4.8

4.6

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

371

0.86

0.33

1.1

1.3

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

778

1.09

0.32

6.9

6.7

47.71

5682.40

u/ml

0.67

141

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

173

1.21

0.32

1.0

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

397

1.13

0.32

1.0

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

407

1.13

0.32

1.1

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

578

1.11

0.32

3.6

4.2

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.30

0.31

1.0

—

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

946

0.92

0.31

2.7

2.9

45.34

41.25

1.45

518

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.73

0.30

1.0

—

(3003157) Bacteria [#/volume] in Mother's milk

1.27

0.30

3.7

7.8

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.27

0.30

1.1

1.0

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

271

0.85

0.29

3.1

39.78

43.39

0.33

271

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

118

1104

1.07

0.28

2.5

2.7

0.90

0.71

e9/l

3.06

110

1070

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

270

0.85

0.28

6.3

6.1

8.91

8.58

0.08

270

(3007700) Barley IgE Ab [Units/volume] in Serum

112

1.25

0.28

1.0

1.1

0.06

13.93

u/ml

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

158

1.20

0.28

1.1

1.2

—

(3050129) First trimester maternal screen panel - Serum or Plasma

924

9041

1.02

0.28

1.7

1.4

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

625

1.09

0.26

1.0

1.1

—

(3020650) Glucose [Presence] in Urine

635

1.09

0.26

1.8

1.5

0.13

0.04

estimate

0.67

635

(3019174) dRVVT (LA screen)

169

1.18

0.25

1.2

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

216

1.16

0.25

2.3

1.9

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

207

1.16

0.25

1.0

0.02

0.55

u/ml

1.74

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

202

0.84

0.24

1.1

1.0

—

(3022475) Manganese [Moles/volume] in Blood

126

0.79

0.24

1.1

1.3

0.14

0.16

umol/l

—

126

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

436

1.10

0.24

1.2

1.1

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

102

958

1.07

0.23

1.4

1.6

3555934.86

1987861.28

iu/ml

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

1.32

0.23

1.0

1.1

4.00

3.08

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

427

4151

1.03

0.23

1.3

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

210

0.86

0.22

1.1

1.4

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

167

1597

1.05

0.21

1.1

—

(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid

0.00

0.21

0.0

1.0

—

(3025830) Chlamydophila pneumoniae IgM Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

21.73

—

(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

1.0

—

(44786798) Granulocytes/Leukocytes in Peritoneal dialysis fluid

0.00

0.21

0.0

2.2

—

(3009992) Blasts/cells in Bone marrow

0.00

0.21

0.0

1.9

—

14.75

—

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

0.21

0.0

1.1

—

(3034614) HLA Ag [Interpretation]

1.16

0.21

1.0

1.3

—

(42528596) U1 small nuclear ribonucleoprotein A Ab [Presence] in Serum by Line blot

1.16

0.21

1.0

—

(42528597) U1 small nuclear ribonucleoprotein C Ab [Presence] in Serum by Line blot

1.16

0.21

1.0

—

(3045759) Histamine [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.7

—

(3024869) Neuronal Ab [Presence] in Serum

268

1.12

0.20

1.0

1.1

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

230

1.13

0.20

1.4

1.2

1.49

1.76

mmol/l

0.36

135

(3046861) Legionella sp Ag [Presence] in Urine

1.25

0.20

1.2

1.0

—

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

217

0.88

0.18

1.1

—

(3028029) Mesothelial cells/Leukocytes in Pleural fluid

164

0.85

0.18

1.2

1.4

6.80

10.68

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

119

1.18

0.17

1.4

1.6

—

(40758358) Immune stain study

1.13

0.17

1.0

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

163

0.86

0.17

1.6

2.6

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

121

1159

1.04

0.16

1.2

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

120

0.83

0.16

1.2

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

409

1.08

0.15

1.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

101

966

1.05

0.15

1.3

1.4

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

159

1.13

0.15

1.0

1.1

—

(3009677) Dengue virus Ab [Presence] in Serum

1.10

0.15

1.1

—

(3007463) Buprenorphine [Presence] in Urine

103

1.17

0.13

6.2

7.2

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

150

1547

0.97

0.13

1.1

16.41

18.80

u/ml

0.52

695

(3042010) Triglyceride [Moles/volume] in Pleural fluid

190

1.11

0.12

1.5

1.3

0.38

1.54

mmol/l

2.16

122

(3020123) Porphyrins [Interpretation] in Serum or Plasma

104

1.15

0.12

1.2

1.0

—

(40765096) Chromosome analysis panel by Banding

405

0.94

0.11

1.3

1.1

—

(3045142) Bone marrow Pathology biopsy report

149

1533

0.97

0.11

1.2

1.4

—

(21494814) CD8 cells/Lymphocytes in Specimen

627

0.96

0.10

1.5

2.2

26.05

30.92

2.11

627

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

860

0.96

0.10

1.3

78.00

66.58

—

102

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

242

1.07

0.09

1.1

1.0

—

(44806420) Estimation of glomerular filtration rate

236

2320

1.02

0.08

2.5

2.3

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

328

3325

0.99

0.08

1.7

—

(40763590) HLA-DQ beta [Type]

0.82

0.07

1.0

—

(40760409) HLA-A [Type] by High resolution

0.81

0.07

1.0

—

(46236302) HLA-C [Type] by High resolution typing

0.81

0.07

1.0

—

(40760410) HLA-B [Type] by High resolution

0.81

0.07

1.0

—

(3044009) aPTT.lupus sensitive (LA screen)

174

0.92

0.07

1.3

1.2

—

(3013862) HLA-DP [Type]

0.80

0.07

1.0

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

1.03

0.07

1.0

1.1

—

(4133840) Spirometry

438

0.96

0.07

1.1

1.2

—

(3023436) Glucagon [Mass/volume] in Serum or Plasma

1.03

0.07

1.8

2.1

179.67

186.91

ng/l

—

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

285

0.95

0.06

1.7

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

1.11

0.05

1.0

1.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

292

2949

0.99

0.05

1.1

2.28

2.93

eliau/ml

0.89

107

1561

(21494815) CD4 cells/Lymphocytes in Specimen

146

1438

1.02

0.05

1.8

2.3

44.51

40.01

3.21

141

1411

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

714

1.02

0.04

1.1

219.50

311.02

ng/l

0.15

180

(3033099) Centromere Ab [Titer] in Serum

458

1.03

0.03

1.1

—

(3005532) Lymphocytes/Leukocytes in Pleural fluid

379

1.03

0.03

1.3

1.4

66.56

62.44

0.33

316

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

903

0.99

0.03

1.0

234.20

353.76

ng/l

2.19

676

(3001893) Eosinophils/Leukocytes in Pleural fluid

320

1.03

0.03

1.2

1.4

1.12

2.96

1.80

272

(3010503) CD19 cells [#/volume] in Blood

952

0.99

0.02

2.4

2.7

296.78

311.65

e6/l

0.04

930

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

480

0.98

0.02

3.2

3.3

1.80

1.96

ratio

0.39

438

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

172

1.05

0.02

1.1

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

560

1.02

0.02

2.3

2.0

8230.57

8402.44

u/ml

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

539

0.98

0.02

1.3

1.2

14.89

19.94

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

103

1.07

0.02

1.0

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

183

1.04

0.01

3.3

2.4

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

907

0.99

0.01

1.0

30.55

39.54

ng/l

2.34

667

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

236

0.97

0.00

5.8

6.7

10.59

10.78

0.15

236

(3010937) Rubella virus Ab [Presence] in Serum

159

1.01

0.00

1.1

—

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

107

1.03

0.00

1.1

0.07

4.20

u/ml

0.89

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.01

0.00

1.0

1.1

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

905

0.99

0.00

1.0

924.39

760.96

ng/l

2.55

657

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

175

1.03

0.00

1.1

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

325

1.02

0.00

1.1

1.2

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

111

1105

1.00

0.00

5.6

7.2

42.87

51.99

ug/l

0.09

743

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

225

2255

1.00

0.00

1.9

1.8

5165.71

1872.22

titre

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

115

0.96

0.00

1.0

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

343

0.99

0.00

1.7

2.1

2.08

3.08

ug/l

0.58

210

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

0.00

0.0

1.1

—

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

0.99

0.00

1.0

1.2

—

(3007147) Virus identified in Stool by Electron microscopy

0.00

0.0

1.0

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.0

—

(40760512) CD34 cells/cells in Bone marrow

0.00

0.0

1.6

—

(3006498) Trichoderma viride IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3029889) Paecilomyces variottii IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

0.96

-0.00

1.2

2.0

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

0.98

-0.00

2.8

2.1

—

(3014257) Rhodotorula spp IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3026868) Penicillium brevicompactum IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3027114) Cholesterol [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

(3017501) Neutrophils [#/volume] in Blood by Manual count

0.00

-0.00

0.0

1.0

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.99

-0.00

1.1

—

(43054952) inv(16)(p13.1;q22.1)(MYH11,CBFB) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

10.2

—

(3013851) Stachybotrys chartarum IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3042628) Porphyrins [Moles/volume] in Urine

0.00

-0.00

0.0

1.2

—

Mortality – FinRegistry

↥

Association

Association between endpoint E4_OBESITYNAS and mortality.

Females

Parameter	HR [95% CI]	p-value
E4_OBESITYNAS	2.219 [1.99, 2.48]	< 0.001
Birth year	0.999 [0.99, 1.01]	0.862

During the follow-up period (1.1.1998 — 31.12.2019), 3644 out of 40743 females with E4_OBESITYNAS died.

Males

Parameter	HR [95% CI]	p-value
E4_OBESITYNAS	2.399 [2.16, 2.66]	< 0.001
Birth year	0.99 [0.98, 1.0]	0.032

During the follow-up period (1.1.1998 — 31.12.2019), 4004 out of 24666 males with E4_OBESITYNAS died.

Mortality risk

Mortality risk for people of age

years, who have E4_OBESITYNAS.

N-year risk	Females	Males
1	0.233%	0.497%
5	1.528%	2.936%
10	3.373%	7.02%
15	6.864%	13.363%
20	11.998%	22.102%

Relationships between endpoints

↥

Index endpoint: E4_OBESITYNAS – Obesity, other/unspecified

GWS hits: 46

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Obesity, other/unspecified

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints